id	sid	tid	token	lemma	pos
ajbspi-35950	1	1	volume	volume	NOUN
ajbspi-35950	1	2	04	04	NUM
ajbspi-35950	1	3	issue	issue	NOUN
ajbspi-35950	1	4	06	06	NUM
ajbspi-35950	1	5	-	-	SYM
ajbspi-35950	1	6	2024	2024	NUM
ajbspi-35950	1	7	8	8	NUM
ajbspi-35950	1	8	american	american	ADJ
ajbspi-35950	1	9	journal	journal	NOUN
ajbspi-35950	1	10	of	of	ADP
ajbspi-35950	1	11	biomedical	biomedical	PROPN
ajbspi-35950	1	12	science	science	PROPN
ajbspi-35950	1	13	&	&	CCONJ
ajbspi-35950	1	14	pharmaceutical	pharmaceutical	PROPN
ajbspi-35950	1	15	innovation	innovation	NOUN
ajbspi-35950	1	16	(	(	PUNCT
ajbspi-35950	1	17	issn	issn	PROPN
ajbspi-35950	1	18	–	–	PUNCT
ajbspi-35950	1	19	2771	2771	NUM
ajbspi-35950	1	20	-	-	SYM
ajbspi-35950	1	21	2753	2753	NUM
ajbspi-35950	1	22	)	)	PUNCT
ajbspi-35950	1	23	volume	volume	NOUN
ajbspi-35950	1	24	04	04	NUM
ajbspi-35950	1	25	issue	issue	NOUN
ajbspi-35950	1	26	06	06	NUM
ajbspi-35950	1	27	pages	page	NOUN
ajbspi-35950	1	28	:	:	PUNCT
ajbspi-35950	1	29	8	8	NUM
ajbspi-35950	1	30	-	-	SYM
ajbspi-35950	1	31	12	12	NUM
ajbspi-35950	1	32	oclc	oclc	PROPN
ajbspi-35950	1	33	–	–	PUNCT
ajbspi-35950	1	34	1121105677	1121105677	NUM
ajbspi-35950	1	35	publisher	publisher	NOUN
ajbspi-35950	1	36	:	:	PUNCT
ajbspi-35950	1	37	oscar	oscar	NOUN
ajbspi-35950	1	38	publishing	publishing	NOUN
ajbspi-35950	1	39	services	service	NOUN
ajbspi-35950	1	40	servi	servi	PROPN
ajbspi-35950	1	41	abstract	abstract	ADV
ajbspi-35950	1	42	this	this	DET
ajbspi-35950	1	43	article	article	NOUN
ajbspi-35950	1	44	provides	provide	VERB
ajbspi-35950	1	45	a	a	DET
ajbspi-35950	1	46	comprehensive	comprehensive	ADJ
ajbspi-35950	1	47	overview	overview	NOUN
ajbspi-35950	1	48	of	of	ADP
ajbspi-35950	1	49	clinical	clinical	ADJ
ajbspi-35950	1	50	pharmacology	pharmacology	NOUN
ajbspi-35950	1	51	,	,	PUNCT
ajbspi-35950	1	52	highlighting	highlight	VERB
ajbspi-35950	1	53	its	its	PRON
ajbspi-35950	1	54	historical	historical	ADJ
ajbspi-35950	1	55	development	development	NOUN
ajbspi-35950	1	56	,	,	PUNCT
ajbspi-35950	1	57	significance	significance	NOUN
ajbspi-35950	1	58	,	,	PUNCT
ajbspi-35950	1	59	key	key	ADJ
ajbspi-35950	1	60	roles	role	NOUN
ajbspi-35950	1	61	,	,	PUNCT
ajbspi-35950	1	62	and	and	CCONJ
ajbspi-35950	1	63	notable	notable	ADJ
ajbspi-35950	1	64	achievements	achievement	NOUN
ajbspi-35950	1	65	.	.	PUNCT
ajbspi-35950	2	1	it	it	PRON
ajbspi-35950	2	2	explains	explain	VERB
ajbspi-35950	2	3	how	how	SCONJ
ajbspi-35950	2	4	clinical	clinical	ADJ
ajbspi-35950	2	5	pharmacology	pharmacology	NOUN
ajbspi-35950	2	6	has	have	AUX
ajbspi-35950	2	7	evolved	evolve	VERB
ajbspi-35950	2	8	from	from	ADP
ajbspi-35950	2	9	its	its	PRON
ajbspi-35950	2	10	origins	origin	NOUN
ajbspi-35950	2	11	in	in	ADP
ajbspi-35950	2	12	the	the	DET
ajbspi-35950	2	13	early	early	ADJ
ajbspi-35950	2	14	20th	20th	ADJ
ajbspi-35950	2	15	century	century	NOUN
ajbspi-35950	2	16	to	to	ADP
ajbspi-35950	2	17	a	a	DET
ajbspi-35950	2	18	crucial	crucial	ADJ
ajbspi-35950	2	19	discipline	discipline	NOUN
ajbspi-35950	2	20	in	in	ADP
ajbspi-35950	2	21	modern	modern	ADJ
ajbspi-35950	2	22	medicine	medicine	NOUN
ajbspi-35950	2	23	.	.	PUNCT
ajbspi-35950	3	1	the	the	DET
ajbspi-35950	3	2	article	article	NOUN
ajbspi-35950	3	3	elucidates	elucidate	VERB
ajbspi-35950	3	4	the	the	DET
ajbspi-35950	3	5	roles	role	NOUN
ajbspi-35950	3	6	of	of	ADP
ajbspi-35950	3	7	clinical	clinical	ADJ
ajbspi-35950	3	8	pharmacologists	pharmacologist	NOUN
ajbspi-35950	3	9	in	in	ADP
ajbspi-35950	3	10	drug	drug	NOUN
ajbspi-35950	3	11	development	development	NOUN
ajbspi-35950	3	12	and	and	CCONJ
ajbspi-35950	3	13	approval	approval	NOUN
ajbspi-35950	3	14	,	,	PUNCT
ajbspi-35950	3	15	optimizing	optimize	VERB
ajbspi-35950	3	16	therapeutic	therapeutic	ADJ
ajbspi-35950	3	17	regimens	regimen	NOUN
ajbspi-35950	3	18	,	,	PUNCT
ajbspi-35950	3	19	regulatory	regulatory	ADJ
ajbspi-35950	3	20	and	and	CCONJ
ajbspi-35950	3	21	policy	policy	NOUN
ajbspi-35950	3	22	development	development	NOUN
ajbspi-35950	3	23	,	,	PUNCT
ajbspi-35950	3	24	education	education	NOUN
ajbspi-35950	3	25	and	and	CCONJ
ajbspi-35950	3	26	training	training	NOUN
ajbspi-35950	3	27	,	,	PUNCT
ajbspi-35950	3	28	and	and	CCONJ
ajbspi-35950	3	29	clinical	clinical	ADJ
ajbspi-35950	3	30	research	research	NOUN
ajbspi-35950	3	31	and	and	CCONJ
ajbspi-35950	3	32	innovations	innovation	NOUN
ajbspi-35950	3	33	.	.	PUNCT
ajbspi-35950	4	1	it	it	PRON
ajbspi-35950	4	2	also	also	ADV
ajbspi-35950	4	3	outlines	outline	VERB
ajbspi-35950	4	4	significant	significant	ADJ
ajbspi-35950	4	5	achievements	achievement	NOUN
ajbspi-35950	4	6	,	,	PUNCT
ajbspi-35950	4	7	such	such	ADJ
ajbspi-35950	4	8	as	as	ADP
ajbspi-35950	4	9	the	the	DET
ajbspi-35950	4	10	advent	advent	NOUN
ajbspi-35950	4	11	of	of	ADP
ajbspi-35950	4	12	precision	precision	NOUN
ajbspi-35950	4	13	medicine	medicine	NOUN
ajbspi-35950	4	14	,	,	PUNCT
ajbspi-35950	4	15	improvements	improvement	NOUN
ajbspi-35950	4	16	in	in	ADP
ajbspi-35950	4	17	drug	drug	NOUN
ajbspi-35950	4	18	safety	safety	NOUN
ajbspi-35950	4	19	and	and	CCONJ
ajbspi-35950	4	20	pharmacovigilance	pharmacovigilance	NOUN
ajbspi-35950	4	21	,	,	PUNCT
ajbspi-35950	4	22	advancements	advancement	NOUN
ajbspi-35950	4	23	in	in	ADP
ajbspi-35950	4	24	chronic	chronic	ADJ
ajbspi-35950	4	25	disease	disease	NOUN
ajbspi-35950	4	26	management	management	NOUN
ajbspi-35950	4	27	,	,	PUNCT
ajbspi-35950	4	28	and	and	CCONJ
ajbspi-35950	4	29	enhanced	enhance	VERB
ajbspi-35950	4	30	therapeutic	therapeutic	ADJ
ajbspi-35950	4	31	outcomes	outcome	NOUN
ajbspi-35950	4	32	.	.	PUNCT
ajbspi-35950	5	1	finally	finally	ADV
ajbspi-35950	5	2	,	,	PUNCT
ajbspi-35950	5	3	the	the	DET
ajbspi-35950	5	4	article	article	NOUN
ajbspi-35950	5	5	looks	look	VERB
ajbspi-35950	5	6	ahead	ahead	ADV
ajbspi-35950	5	7	to	to	ADP
ajbspi-35950	5	8	future	future	ADJ
ajbspi-35950	5	9	directions	direction	NOUN
ajbspi-35950	5	10	in	in	ADP
ajbspi-35950	5	11	the	the	DET
ajbspi-35950	5	12	field	field	NOUN
ajbspi-35950	5	13	,	,	PUNCT
ajbspi-35950	5	14	emphasizing	emphasize	VERB
ajbspi-35950	5	15	the	the	DET
ajbspi-35950	5	16	potential	potential	ADJ
ajbspi-35950	5	17	impact	impact	NOUN
ajbspi-35950	5	18	of	of	ADP
ajbspi-35950	5	19	digital	digital	ADJ
ajbspi-35950	5	20	health	health	NOUN
ajbspi-35950	5	21	,	,	PUNCT
ajbspi-35950	5	22	artificial	artificial	ADJ
ajbspi-35950	5	23	intelligence	intelligence	NOUN
ajbspi-35950	5	24	,	,	PUNCT
ajbspi-35950	5	25	pharmacogenomics	pharmacogenomic	NOUN
ajbspi-35950	5	26	,	,	PUNCT
ajbspi-35950	5	27	and	and	CCONJ
ajbspi-35950	5	28	biotechnology	biotechnology	NOUN
ajbspi-35950	5	29	.	.	PUNCT
ajbspi-35950	6	1	keywords	keyword	VERB
ajbspi-35950	6	2	clinical	clinical	ADJ
ajbspi-35950	6	3	pharmacology	pharmacology	NOUN
ajbspi-35950	6	4	,	,	PUNCT
ajbspi-35950	6	5	drug	drug	NOUN
ajbspi-35950	6	6	development	development	NOUN
ajbspi-35950	6	7	,	,	PUNCT
ajbspi-35950	6	8	drug	drug	NOUN
ajbspi-35950	6	9	safety	safety	NOUN
ajbspi-35950	6	10	,	,	PUNCT
ajbspi-35950	6	11	pharmacovigilance	pharmacovigilance	NOUN
ajbspi-35950	6	12	,	,	PUNCT
ajbspi-35950	6	13	pharmacokinetics	pharmacokinetic	NOUN
ajbspi-35950	6	14	,	,	PUNCT
ajbspi-35950	6	15	chronic	chronic	ADJ
ajbspi-35950	6	16	disease	disease	NOUN
ajbspi-35950	6	17	management	management	NOUN
ajbspi-35950	6	18	,	,	PUNCT
ajbspi-35950	6	19	gene	gene	NOUN
ajbspi-35950	6	20	therapy	therapy	NOUN
ajbspi-35950	6	21	,	,	PUNCT
ajbspi-35950	6	22	biotechnology	biotechnology	NOUN
ajbspi-35950	6	23	,	,	PUNCT
ajbspi-35950	6	24	digital	digital	ADJ
ajbspi-35950	6	25	health	health	NOUN
ajbspi-35950	6	26	,	,	PUNCT
ajbspi-35950	6	27	artificial	artificial	ADJ
ajbspi-35950	6	28	intelligence	intelligence	NOUN
ajbspi-35950	6	29	,	,	PUNCT
ajbspi-35950	6	30	telemedicine	telemedicine	NOUN
ajbspi-35950	6	31	,	,	PUNCT
ajbspi-35950	6	32	real	real	ADJ
ajbspi-35950	6	33	-	-	PUNCT
ajbspi-35950	6	34	world	world	NOUN
ajbspi-35950	6	35	evidence	evidence	NOUN
ajbspi-35950	6	36	,	,	PUNCT
ajbspi-35950	6	37	clinical	clinical	ADJ
ajbspi-35950	6	38	trials	trial	NOUN
ajbspi-35950	6	39	.	.	PUNCT
ajbspi-35950	7	1	introduction	introduction	NOUN
ajbspi-35950	7	2	research	research	NOUN
ajbspi-35950	7	3	article	article	NOUN
ajbspi-35950	7	4	the	the	DET
ajbspi-35950	7	5	evolution	evolution	NOUN
ajbspi-35950	7	6	of	of	ADP
ajbspi-35950	7	7	clinical	clinical	ADJ
ajbspi-35950	7	8	pharmacology	pharmacology	NOUN
ajbspi-35950	7	9	:	:	PUNCT
ajbspi-35950	7	10	significance	significance	NOUN
ajbspi-35950	7	11	,	,	PUNCT
ajbspi-35950	7	12	role	role	NOUN
ajbspi-35950	7	13	,	,	PUNCT
ajbspi-35950	7	14	and	and	CCONJ
ajbspi-35950	7	15	achievements	achievement	VERB
ajbspi-35950	7	16	submission	submission	NOUN
ajbspi-35950	7	17	date	date	NOUN
ajbspi-35950	7	18	:	:	PUNCT
ajbspi-35950	7	19	june	june	PROPN
ajbspi-35950	7	20	01	01	NUM
ajbspi-35950	7	21	,	,	PUNCT
ajbspi-35950	7	22	2024	2024	NUM
ajbspi-35950	7	23	,	,	PUNCT
ajbspi-35950	7	24	accepted	accept	VERB
ajbspi-35950	7	25	date	date	NOUN
ajbspi-35950	7	26	:	:	PUNCT
ajbspi-35950	7	27	june	june	PROPN
ajbspi-35950	7	28	06	06	NUM
ajbspi-35950	7	29	,	,	PUNCT
ajbspi-35950	7	30	2024	2024	NUM
ajbspi-35950	7	31	,	,	PUNCT
ajbspi-35950	7	32	published	publish	VERB
ajbspi-35950	7	33	date	date	NOUN
ajbspi-35950	7	34	:	:	PUNCT
ajbspi-35950	7	35	june	june	PROPN
ajbspi-35950	7	36	11	11	NUM
ajbspi-35950	7	37	,	,	PUNCT
ajbspi-35950	7	38	2024	2024	NUM
ajbspi-35950	7	39	crossref	crossref	NOUN
ajbspi-35950	7	40	doi	doi	NOUN
ajbspi-35950	7	41	:	:	PUNCT
ajbspi-35950	7	42	https://doi.org/10.37547/ajbspi/volume04issue06-02	https://doi.org/10.37547/ajbspi/volume04issue06-02	PROPN
ajbspi-35950	7	43	muradova	muradova	PROPN
ajbspi-35950	7	44	railya	railya	PROPN
ajbspi-35950	7	45	rustamovna	rustamovna	PROPN
ajbspi-35950	7	46	assistant	assistant	NOUN
ajbspi-35950	7	47	at	at	ADP
ajbspi-35950	7	48	the	the	DET
ajbspi-35950	7	49	department	department	NOUN
ajbspi-35950	7	50	of	of	ADP
ajbspi-35950	7	51	clinical	clinical	ADJ
ajbspi-35950	7	52	pharmacology	pharmacology	NOUN
ajbspi-35950	7	53	,	,	PUNCT
ajbspi-35950	7	54	samarkand	samarkand	PROPN
ajbspi-35950	7	55	state	state	PROPN
ajbspi-35950	7	56	medical	medical	PROPN
ajbspi-35950	7	57	university	university	PROPN
ajbspi-35950	7	58	,	,	PUNCT
ajbspi-35950	7	59	samarkand	samarkand	PROPN
ajbspi-35950	7	60	,	,	PUNCT
ajbspi-35950	7	61	uzbekistan	uzbekistan	PROPN
ajbspi-35950	7	62	journal	journal	PROPN
ajbspi-35950	7	63	website	website	NOUN
ajbspi-35950	7	64	:	:	PUNCT
ajbspi-35950	7	65	https://theusajournals	https://theusajournals	PROPN
ajbspi-35950	7	66	.	.	PUNCT
ajbspi-35950	7	67	com	com	NOUN
ajbspi-35950	7	68	/	/	SYM
ajbspi-35950	7	69	index.php	index.php	VERB
ajbspi-35950	7	70	/	/	SYM
ajbspi-35950	7	71	ajbspi	ajbspi	NOUN
ajbspi-35950	7	72	copyright	copyright	NOUN
ajbspi-35950	7	73	:	:	PUNCT
ajbspi-35950	7	74	original	original	ADJ
ajbspi-35950	7	75	content	content	NOUN
ajbspi-35950	7	76	from	from	ADP
ajbspi-35950	7	77	this	this	DET
ajbspi-35950	7	78	work	work	NOUN
ajbspi-35950	7	79	may	may	AUX
ajbspi-35950	7	80	be	be	AUX
ajbspi-35950	7	81	used	use	VERB
ajbspi-35950	7	82	under	under	ADP
ajbspi-35950	7	83	the	the	DET
ajbspi-35950	7	84	terms	term	NOUN
ajbspi-35950	7	85	of	of	ADP
ajbspi-35950	7	86	the	the	DET
ajbspi-35950	7	87	creative	creative	ADJ
ajbspi-35950	7	88	commons	common	NOUN
ajbspi-35950	7	89	attributes	attribute	VERB
ajbspi-35950	7	90	4.0	4.0	NUM
ajbspi-35950	7	91	licence	licence	NOUN
ajbspi-35950	7	92	.	.	PUNCT
ajbspi-35950	8	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-35950	8	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-35950	8	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	VERB
ajbspi-35950	8	4	https://theusajournals.com/	https://theusajournals.com/	PROPN
ajbspi-35950	8	5	https://doi.org/10.37547/ajbspi/volume04issue06-02	https://doi.org/10.37547/ajbspi/volume04issue06-02	PROPN
ajbspi-35950	8	6	https://doi.org/10.37547/ajbspi/volume04issue06-02	https://doi.org/10.37547/ajbspi/volume04issue06-02	PROPN
ajbspi-35950	8	7	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-35950	8	8	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-35950	8	9	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-35950	8	10	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-35950	8	11	volume	volume	NOUN
ajbspi-35950	8	12	04	04	NUM
ajbspi-35950	8	13	issue	issue	NOUN
ajbspi-35950	8	14	06	06	NUM
ajbspi-35950	8	15	-	-	SYM
ajbspi-35950	8	16	2024	2024	NUM
ajbspi-35950	8	17	9	9	NUM
ajbspi-35950	8	18	american	american	ADJ
ajbspi-35950	8	19	journal	journal	PROPN
ajbspi-35950	8	20	of	of	ADP
ajbspi-35950	8	21	biomedical	biomedical	PROPN
ajbspi-35950	8	22	science	science	PROPN
ajbspi-35950	8	23	&	&	CCONJ
ajbspi-35950	8	24	pharmaceutical	pharmaceutical	PROPN
ajbspi-35950	8	25	innovation	innovation	NOUN
ajbspi-35950	8	26	(	(	PUNCT
ajbspi-35950	8	27	issn	issn	PROPN
ajbspi-35950	8	28	–	–	PUNCT
ajbspi-35950	8	29	2771	2771	NUM
ajbspi-35950	8	30	-	-	SYM
ajbspi-35950	8	31	2753	2753	NUM
ajbspi-35950	8	32	)	)	PUNCT
ajbspi-35950	8	33	volume	volume	NOUN
ajbspi-35950	8	34	04	04	NUM
ajbspi-35950	8	35	issue	issue	NOUN
ajbspi-35950	8	36	06	06	NUM
ajbspi-35950	8	37	pages	page	NOUN
ajbspi-35950	8	38	:	:	PUNCT
ajbspi-35950	8	39	8	8	NUM
ajbspi-35950	8	40	-	-	SYM
ajbspi-35950	8	41	12	12	NUM
ajbspi-35950	8	42	oclc	oclc	PROPN
ajbspi-35950	8	43	–	–	PUNCT
ajbspi-35950	8	44	1121105677	1121105677	NUM
ajbspi-35950	8	45	publisher	publisher	NOUN
ajbspi-35950	8	46	:	:	PUNCT
ajbspi-35950	8	47	oscar	oscar	NOUN
ajbspi-35950	8	48	publishing	publishing	NOUN
ajbspi-35950	8	49	services	service	NOUN
ajbspi-35950	8	50	servi	servi	PROPN
ajbspi-35950	8	51	clinical	clinical	ADJ
ajbspi-35950	8	52	pharmacology	pharmacology	NOUN
ajbspi-35950	8	53	is	be	AUX
ajbspi-35950	8	54	a	a	DET
ajbspi-35950	8	55	vital	vital	ADJ
ajbspi-35950	8	56	discipline	discipline	NOUN
ajbspi-35950	8	57	within	within	ADP
ajbspi-35950	8	58	the	the	DET
ajbspi-35950	8	59	medical	medical	ADJ
ajbspi-35950	8	60	sciences	science	NOUN
ajbspi-35950	8	61	,	,	PUNCT
ajbspi-35950	8	62	focusing	focus	VERB
ajbspi-35950	8	63	on	on	ADP
ajbspi-35950	8	64	understanding	understand	VERB
ajbspi-35950	8	65	the	the	DET
ajbspi-35950	8	66	interactions	interaction	NOUN
ajbspi-35950	8	67	between	between	ADP
ajbspi-35950	8	68	drugs	drug	NOUN
ajbspi-35950	8	69	and	and	CCONJ
ajbspi-35950	8	70	the	the	DET
ajbspi-35950	8	71	human	human	ADJ
ajbspi-35950	8	72	body	body	NOUN
ajbspi-35950	8	73	to	to	PART
ajbspi-35950	8	74	optimize	optimize	VERB
ajbspi-35950	8	75	therapeutic	therapeutic	ADJ
ajbspi-35950	8	76	outcomes	outcome	NOUN
ajbspi-35950	8	77	while	while	SCONJ
ajbspi-35950	8	78	minimizing	minimize	VERB
ajbspi-35950	8	79	adverse	adverse	ADJ
ajbspi-35950	8	80	effects	effect	NOUN
ajbspi-35950	8	81	.	.	PUNCT
ajbspi-35950	9	1	this	this	DET
ajbspi-35950	9	2	field	field	NOUN
ajbspi-35950	9	3	has	have	AUX
ajbspi-35950	9	4	undergone	undergo	VERB
ajbspi-35950	9	5	significant	significant	ADJ
ajbspi-35950	9	6	evolution	evolution	NOUN
ajbspi-35950	9	7	since	since	SCONJ
ajbspi-35950	9	8	its	its	PRON
ajbspi-35950	9	9	inception	inception	NOUN
ajbspi-35950	9	10	,	,	PUNCT
ajbspi-35950	9	11	driven	drive	VERB
ajbspi-35950	9	12	by	by	ADP
ajbspi-35950	9	13	advances	advance	NOUN
ajbspi-35950	9	14	in	in	ADP
ajbspi-35950	9	15	technology	technology	NOUN
ajbspi-35950	9	16	,	,	PUNCT
ajbspi-35950	9	17	medical	medical	ADJ
ajbspi-35950	9	18	knowledge	knowledge	NOUN
ajbspi-35950	9	19	,	,	PUNCT
ajbspi-35950	9	20	and	and	CCONJ
ajbspi-35950	9	21	regulatory	regulatory	ADJ
ajbspi-35950	9	22	frameworks	framework	NOUN
ajbspi-35950	9	23	.	.	PUNCT
ajbspi-35950	10	1	in	in	ADP
ajbspi-35950	10	2	this	this	DET
ajbspi-35950	10	3	article	article	NOUN
ajbspi-35950	10	4	,	,	PUNCT
ajbspi-35950	10	5	we	we	PRON
ajbspi-35950	10	6	delve	delve	VERB
ajbspi-35950	10	7	into	into	ADP
ajbspi-35950	10	8	the	the	DET
ajbspi-35950	10	9	historical	historical	ADJ
ajbspi-35950	10	10	development	development	NOUN
ajbspi-35950	10	11	of	of	ADP
ajbspi-35950	10	12	clinical	clinical	ADJ
ajbspi-35950	10	13	pharmacology	pharmacology	NOUN
ajbspi-35950	10	14	,	,	PUNCT
ajbspi-35950	10	15	its	its	PRON
ajbspi-35950	10	16	significance	significance	NOUN
ajbspi-35950	10	17	,	,	PUNCT
ajbspi-35950	10	18	key	key	ADJ
ajbspi-35950	10	19	roles	role	NOUN
ajbspi-35950	10	20	,	,	PUNCT
ajbspi-35950	10	21	and	and	CCONJ
ajbspi-35950	10	22	notable	notable	ADJ
ajbspi-35950	10	23	achievements	achievement	NOUN
ajbspi-35950	10	24	.	.	PUNCT
ajbspi-35950	11	1	historical	historical	ADJ
ajbspi-35950	11	2	development	development	NOUN
ajbspi-35950	11	3	the	the	DET
ajbspi-35950	11	4	origins	origin	NOUN
ajbspi-35950	11	5	of	of	ADP
ajbspi-35950	11	6	clinical	clinical	ADJ
ajbspi-35950	11	7	pharmacology	pharmacology	NOUN
ajbspi-35950	11	8	can	can	AUX
ajbspi-35950	11	9	be	be	AUX
ajbspi-35950	11	10	traced	trace	VERB
ajbspi-35950	11	11	back	back	ADV
ajbspi-35950	11	12	to	to	ADP
ajbspi-35950	11	13	the	the	DET
ajbspi-35950	11	14	early	early	ADJ
ajbspi-35950	11	15	20th	20th	ADJ
ajbspi-35950	11	16	century	century	NOUN
ajbspi-35950	11	17	when	when	SCONJ
ajbspi-35950	11	18	the	the	DET
ajbspi-35950	11	19	need	need	NOUN
ajbspi-35950	11	20	for	for	ADP
ajbspi-35950	11	21	systematic	systematic	ADJ
ajbspi-35950	11	22	drug	drug	NOUN
ajbspi-35950	11	23	testing	testing	NOUN
ajbspi-35950	11	24	and	and	CCONJ
ajbspi-35950	11	25	evaluation	evaluation	NOUN
ajbspi-35950	11	26	became	become	VERB
ajbspi-35950	11	27	apparent	apparent	ADJ
ajbspi-35950	11	28	.	.	PUNCT
ajbspi-35950	12	1	advances	advance	NOUN
ajbspi-35950	12	2	in	in	ADP
ajbspi-35950	12	3	physiology	physiology	NOUN
ajbspi-35950	12	4	,	,	PUNCT
ajbspi-35950	12	5	biochemistry	biochemistry	NOUN
ajbspi-35950	12	6	,	,	PUNCT
ajbspi-35950	12	7	and	and	CCONJ
ajbspi-35950	12	8	molecular	molecular	ADJ
ajbspi-35950	12	9	biology	biology	NOUN
ajbspi-35950	12	10	laid	lay	VERB
ajbspi-35950	12	11	the	the	DET
ajbspi-35950	12	12	groundwork	groundwork	NOUN
ajbspi-35950	12	13	for	for	ADP
ajbspi-35950	12	14	understanding	understand	VERB
ajbspi-35950	12	15	how	how	SCONJ
ajbspi-35950	12	16	drugs	drug	NOUN
ajbspi-35950	12	17	affect	affect	VERB
ajbspi-35950	12	18	biological	biological	ADJ
ajbspi-35950	12	19	systems	system	NOUN
ajbspi-35950	12	20	.	.	PUNCT
ajbspi-35950	13	1	the	the	DET
ajbspi-35950	13	2	discipline	discipline	NOUN
ajbspi-35950	13	3	began	begin	VERB
ajbspi-35950	13	4	to	to	PART
ajbspi-35950	13	5	take	take	VERB
ajbspi-35950	13	6	shape	shape	NOUN
ajbspi-35950	13	7	with	with	ADP
ajbspi-35950	13	8	the	the	DET
ajbspi-35950	13	9	introduction	introduction	NOUN
ajbspi-35950	13	10	of	of	ADP
ajbspi-35950	13	11	randomized	randomized	ADJ
ajbspi-35950	13	12	controlled	control	VERB
ajbspi-35950	13	13	trials	trial	NOUN
ajbspi-35950	13	14	(	(	PUNCT
ajbspi-35950	13	15	rcts	rct	NOUN
ajbspi-35950	13	16	)	)	PUNCT
ajbspi-35950	13	17	in	in	ADP
ajbspi-35950	13	18	the	the	DET
ajbspi-35950	13	19	mid-20th	mid-20th	NUM
ajbspi-35950	13	20	century	century	NOUN
ajbspi-35950	13	21	,	,	PUNCT
ajbspi-35950	13	22	which	which	PRON
ajbspi-35950	13	23	provided	provide	VERB
ajbspi-35950	13	24	a	a	DET
ajbspi-35950	13	25	scientific	scientific	ADJ
ajbspi-35950	13	26	basis	basis	NOUN
ajbspi-35950	13	27	for	for	ADP
ajbspi-35950	13	28	evaluating	evaluate	VERB
ajbspi-35950	13	29	drug	drug	NOUN
ajbspi-35950	13	30	efficacy	efficacy	NOUN
ajbspi-35950	13	31	and	and	CCONJ
ajbspi-35950	13	32	safety	safety	NOUN
ajbspi-35950	13	33	.	.	PUNCT
ajbspi-35950	14	1	the	the	DET
ajbspi-35950	14	2	1960s	1960	NOUN
ajbspi-35950	14	3	and	and	CCONJ
ajbspi-35950	14	4	1970s	1970	NOUN
ajbspi-35950	14	5	saw	see	VERB
ajbspi-35950	14	6	the	the	DET
ajbspi-35950	14	7	establishment	establishment	NOUN
ajbspi-35950	14	8	of	of	ADP
ajbspi-35950	14	9	formal	formal	ADJ
ajbspi-35950	14	10	academic	academic	ADJ
ajbspi-35950	14	11	programs	program	NOUN
ajbspi-35950	14	12	in	in	ADP
ajbspi-35950	14	13	clinical	clinical	ADJ
ajbspi-35950	14	14	pharmacology	pharmacology	NOUN
ajbspi-35950	14	15	,	,	PUNCT
ajbspi-35950	14	16	as	as	ADV
ajbspi-35950	14	17	well	well	ADV
ajbspi-35950	14	18	as	as	ADP
ajbspi-35950	14	19	the	the	DET
ajbspi-35950	14	20	creation	creation	NOUN
ajbspi-35950	14	21	of	of	ADP
ajbspi-35950	14	22	regulatory	regulatory	ADJ
ajbspi-35950	14	23	bodies	body	NOUN
ajbspi-35950	14	24	like	like	ADP
ajbspi-35950	14	25	the	the	DET
ajbspi-35950	14	26	u.s	u.s	PROPN
ajbspi-35950	14	27	.	.	PROPN
ajbspi-35950	14	28	food	food	PROPN
ajbspi-35950	14	29	and	and	CCONJ
ajbspi-35950	14	30	drug	drug	PROPN
ajbspi-35950	14	31	administration	administration	PROPN
ajbspi-35950	14	32	(	(	PUNCT
ajbspi-35950	14	33	fda	fda	PROPN
ajbspi-35950	14	34	)	)	PUNCT
ajbspi-35950	14	35	and	and	CCONJ
ajbspi-35950	14	36	the	the	DET
ajbspi-35950	14	37	european	european	PROPN
ajbspi-35950	14	38	medicines	medicines	PROPN
ajbspi-35950	14	39	agency	agency	NOUN
ajbspi-35950	14	40	(	(	PUNCT
ajbspi-35950	14	41	ema	ema	PROPN
ajbspi-35950	14	42	)	)	PUNCT
ajbspi-35950	14	43	,	,	PUNCT
ajbspi-35950	14	44	which	which	PRON
ajbspi-35950	14	45	began	begin	VERB
ajbspi-35950	14	46	to	to	PART
ajbspi-35950	14	47	rigorously	rigorously	ADV
ajbspi-35950	14	48	evaluate	evaluate	VERB
ajbspi-35950	14	49	new	new	ADJ
ajbspi-35950	14	50	drugs	drug	NOUN
ajbspi-35950	14	51	.	.	PUNCT
ajbspi-35950	15	1	these	these	DET
ajbspi-35950	15	2	developments	development	NOUN
ajbspi-35950	15	3	marked	mark	VERB
ajbspi-35950	15	4	the	the	DET
ajbspi-35950	15	5	transition	transition	NOUN
ajbspi-35950	15	6	of	of	ADP
ajbspi-35950	15	7	clinical	clinical	ADJ
ajbspi-35950	15	8	pharmacology	pharmacology	NOUN
ajbspi-35950	15	9	from	from	ADP
ajbspi-35950	15	10	a	a	DET
ajbspi-35950	15	11	predominantly	predominantly	ADV
ajbspi-35950	15	12	research	research	NOUN
ajbspi-35950	15	13	-	-	PUNCT
ajbspi-35950	15	14	focused	focus	VERB
ajbspi-35950	15	15	field	field	NOUN
ajbspi-35950	15	16	to	to	ADP
ajbspi-35950	15	17	one	one	NUM
ajbspi-35950	15	18	that	that	PRON
ajbspi-35950	15	19	also	also	ADV
ajbspi-35950	15	20	emphasized	emphasize	VERB
ajbspi-35950	15	21	patient	patient	ADJ
ajbspi-35950	15	22	care	care	NOUN
ajbspi-35950	15	23	and	and	CCONJ
ajbspi-35950	15	24	public	public	ADJ
ajbspi-35950	15	25	health	health	NOUN
ajbspi-35950	15	26	.	.	PUNCT
ajbspi-35950	15	27	significance	significance	NOUN
ajbspi-35950	15	28	and	and	CCONJ
ajbspi-35950	15	29	role	role	NOUN
ajbspi-35950	15	30	1	1	NUM
ajbspi-35950	15	31	.	.	PUNCT
ajbspi-35950	15	32	drug	drug	NOUN
ajbspi-35950	15	33	development	development	NOUN
ajbspi-35950	15	34	and	and	CCONJ
ajbspi-35950	15	35	approval	approval	NOUN
ajbspi-35950	15	36	:	:	PUNCT
ajbspi-35950	15	37	clinical	clinical	ADJ
ajbspi-35950	15	38	pharmacologists	pharmacologist	NOUN
ajbspi-35950	15	39	are	be	AUX
ajbspi-35950	15	40	integral	integral	ADJ
ajbspi-35950	15	41	to	to	ADP
ajbspi-35950	15	42	the	the	DET
ajbspi-35950	15	43	drug	drug	NOUN
ajbspi-35950	15	44	development	development	NOUN
ajbspi-35950	15	45	process	process	NOUN
ajbspi-35950	15	46	.	.	PUNCT
ajbspi-35950	16	1	from	from	ADP
ajbspi-35950	16	2	preclinical	preclinical	ADJ
ajbspi-35950	16	3	studies	study	NOUN
ajbspi-35950	16	4	to	to	PART
ajbspi-35950	16	5	phase	phase	VERB
ajbspi-35950	16	6	i	i	PRON
ajbspi-35950	16	7	-	-	PUNCT
ajbspi-35950	16	8	iv	iv	NUM
ajbspi-35950	16	9	clinical	clinical	ADJ
ajbspi-35950	16	10	trials	trial	NOUN
ajbspi-35950	16	11	,	,	PUNCT
ajbspi-35950	16	12	these	these	DET
ajbspi-35950	16	13	professionals	professional	NOUN
ajbspi-35950	16	14	assess	assess	VERB
ajbspi-35950	16	15	the	the	DET
ajbspi-35950	16	16	pharmacokinetics	pharmacokinetic	NOUN
ajbspi-35950	16	17	and	and	CCONJ
ajbspi-35950	16	18	pharmacodynamics	pharmacodynamic	NOUN
ajbspi-35950	16	19	of	of	ADP
ajbspi-35950	16	20	new	new	ADJ
ajbspi-35950	16	21	compounds	compound	NOUN
ajbspi-35950	16	22	.	.	PUNCT
ajbspi-35950	17	1	they	they	PRON
ajbspi-35950	17	2	also	also	ADV
ajbspi-35950	17	3	design	design	VERB
ajbspi-35950	17	4	and	and	CCONJ
ajbspi-35950	17	5	interpret	interpret	VERB
ajbspi-35950	17	6	clinical	clinical	ADJ
ajbspi-35950	17	7	trials	trial	NOUN
ajbspi-35950	17	8	that	that	PRON
ajbspi-35950	17	9	test	test	VERB
ajbspi-35950	17	10	the	the	DET
ajbspi-35950	17	11	efficacy	efficacy	NOUN
ajbspi-35950	17	12	and	and	CCONJ
ajbspi-35950	17	13	safety	safety	NOUN
ajbspi-35950	17	14	of	of	ADP
ajbspi-35950	17	15	new	new	ADJ
ajbspi-35950	17	16	drugs	drug	NOUN
ajbspi-35950	17	17	,	,	PUNCT
ajbspi-35950	17	18	thereby	thereby	ADV
ajbspi-35950	17	19	playing	play	VERB
ajbspi-35950	17	20	a	a	DET
ajbspi-35950	17	21	crucial	crucial	ADJ
ajbspi-35950	17	22	role	role	NOUN
ajbspi-35950	17	23	in	in	ADP
ajbspi-35950	17	24	bringing	bring	VERB
ajbspi-35950	17	25	new	new	ADJ
ajbspi-35950	17	26	therapies	therapy	NOUN
ajbspi-35950	17	27	to	to	ADP
ajbspi-35950	17	28	market	market	NOUN
ajbspi-35950	17	29	.	.	PUNCT
ajbspi-35950	18	1	2	2	X
ajbspi-35950	18	2	.	.	X
ajbspi-35950	18	3	optimizing	optimize	VERB
ajbspi-35950	18	4	therapeutic	therapeutic	ADJ
ajbspi-35950	18	5	regimens	regimen	NOUN
ajbspi-35950	18	6	:	:	PUNCT
ajbspi-35950	18	7	the	the	DET
ajbspi-35950	18	8	goal	goal	NOUN
ajbspi-35950	18	9	of	of	ADP
ajbspi-35950	18	10	clinical	clinical	ADJ
ajbspi-35950	18	11	pharmacology	pharmacology	NOUN
ajbspi-35950	18	12	is	be	AUX
ajbspi-35950	18	13	to	to	PART
ajbspi-35950	18	14	tailor	tailor	VERB
ajbspi-35950	18	15	drug	drug	NOUN
ajbspi-35950	18	16	therapy	therapy	NOUN
ajbspi-35950	18	17	to	to	ADP
ajbspi-35950	18	18	individual	individual	ADJ
ajbspi-35950	18	19	patients	patient	NOUN
ajbspi-35950	18	20	.	.	PUNCT
ajbspi-35950	19	1	this	this	PRON
ajbspi-35950	19	2	includes	include	VERB
ajbspi-35950	19	3	considerations	consideration	NOUN
ajbspi-35950	19	4	of	of	ADP
ajbspi-35950	19	5	dose	dose	NOUN
ajbspi-35950	19	6	-	-	PUNCT
ajbspi-35950	19	7	response	response	NOUN
ajbspi-35950	19	8	relationships	relationship	NOUN
ajbspi-35950	19	9	,	,	PUNCT
ajbspi-35950	19	10	drugdrug	drugdrug	NOUN
ajbspi-35950	19	11	interactions	interaction	NOUN
ajbspi-35950	19	12	,	,	PUNCT
ajbspi-35950	19	13	and	and	CCONJ
ajbspi-35950	19	14	the	the	DET
ajbspi-35950	19	15	impact	impact	NOUN
ajbspi-35950	19	16	of	of	ADP
ajbspi-35950	19	17	genetic	genetic	ADJ
ajbspi-35950	19	18	variability	variability	NOUN
ajbspi-35950	19	19	on	on	ADP
ajbspi-35950	19	20	drug	drug	NOUN
ajbspi-35950	19	21	metabolism	metabolism	NOUN
ajbspi-35950	19	22	and	and	CCONJ
ajbspi-35950	19	23	action	action	NOUN
ajbspi-35950	19	24	.	.	PUNCT
ajbspi-35950	20	1	such	such	ADJ
ajbspi-35950	20	2	personalized	personalized	ADJ
ajbspi-35950	20	3	approaches	approach	NOUN
ajbspi-35950	20	4	aim	aim	VERB
ajbspi-35950	20	5	to	to	PART
ajbspi-35950	20	6	maximize	maximize	VERB
ajbspi-35950	20	7	therapeutic	therapeutic	ADJ
ajbspi-35950	20	8	benefits	benefit	NOUN
ajbspi-35950	20	9	while	while	SCONJ
ajbspi-35950	20	10	minimizing	minimize	VERB
ajbspi-35950	20	11	risks	risk	NOUN
ajbspi-35950	20	12	.	.	PUNCT
ajbspi-35950	21	1	3	3	X
ajbspi-35950	21	2	.	.	X
ajbspi-35950	21	3	regulatory	regulatory	ADJ
ajbspi-35950	21	4	and	and	CCONJ
ajbspi-35950	21	5	policy	policy	NOUN
ajbspi-35950	21	6	development	development	NOUN
ajbspi-35950	21	7	:	:	PUNCT
ajbspi-35950	21	8	clinical	clinical	ADJ
ajbspi-35950	21	9	pharmacologists	pharmacologist	NOUN
ajbspi-35950	21	10	contribute	contribute	VERB
ajbspi-35950	21	11	to	to	ADP
ajbspi-35950	21	12	the	the	DET
ajbspi-35950	21	13	development	development	NOUN
ajbspi-35950	21	14	of	of	ADP
ajbspi-35950	21	15	guidelines	guideline	NOUN
ajbspi-35950	21	16	and	and	CCONJ
ajbspi-35950	21	17	policies	policy	NOUN
ajbspi-35950	21	18	that	that	PRON
ajbspi-35950	21	19	govern	govern	VERB
ajbspi-35950	21	20	the	the	DET
ajbspi-35950	21	21	use	use	NOUN
ajbspi-35950	21	22	of	of	ADP
ajbspi-35950	21	23	drugs	drug	NOUN
ajbspi-35950	21	24	.	.	PUNCT
ajbspi-35950	22	1	their	their	PRON
ajbspi-35950	22	2	expertise	expertise	NOUN
ajbspi-35950	22	3	helps	help	VERB
ajbspi-35950	22	4	shape	shape	VERB
ajbspi-35950	22	5	regulations	regulation	NOUN
ajbspi-35950	22	6	that	that	PRON
ajbspi-35950	22	7	ensure	ensure	VERB
ajbspi-35950	22	8	medications	medication	NOUN
ajbspi-35950	22	9	are	be	AUX
ajbspi-35950	22	10	safe	safe	ADJ
ajbspi-35950	22	11	,	,	PUNCT
ajbspi-35950	22	12	effective	effective	ADJ
ajbspi-35950	22	13	,	,	PUNCT
ajbspi-35950	22	14	and	and	CCONJ
ajbspi-35950	22	15	available	available	ADJ
ajbspi-35950	22	16	to	to	ADP
ajbspi-35950	22	17	those	those	PRON
ajbspi-35950	22	18	who	who	PRON
ajbspi-35950	22	19	need	need	VERB
ajbspi-35950	22	20	them	they	PRON
ajbspi-35950	22	21	.	.	PUNCT
ajbspi-35950	23	1	this	this	PRON
ajbspi-35950	23	2	includes	include	VERB
ajbspi-35950	23	3	involvement	involvement	NOUN
ajbspi-35950	23	4	in	in	ADP
ajbspi-35950	23	5	pharmacovigilance	pharmacovigilance	NOUN
ajbspi-35950	23	6	activities	activity	NOUN
ajbspi-35950	23	7	to	to	PART
ajbspi-35950	23	8	monitor	monitor	VERB
ajbspi-35950	23	9	adverse	adverse	ADJ
ajbspi-35950	23	10	drug	drug	NOUN
ajbspi-35950	23	11	reactions	reaction	NOUN
ajbspi-35950	23	12	and	and	CCONJ
ajbspi-35950	23	13	ensure	ensure	VERB
ajbspi-35950	23	14	ongoing	ongoing	ADJ
ajbspi-35950	23	15	drug	drug	NOUN
ajbspi-35950	23	16	safety	safety	NOUN
ajbspi-35950	23	17	.	.	PUNCT
ajbspi-35950	24	1	4	4	X
ajbspi-35950	24	2	.	.	X
ajbspi-35950	24	3	education	education	NOUN
ajbspi-35950	24	4	and	and	CCONJ
ajbspi-35950	24	5	training	training	NOUN
ajbspi-35950	24	6	:	:	PUNCT
ajbspi-35950	24	7	clinical	clinical	ADJ
ajbspi-35950	24	8	pharmacologists	pharmacologist	NOUN
ajbspi-35950	24	9	are	be	AUX
ajbspi-35950	24	10	essential	essential	ADJ
ajbspi-35950	24	11	educators	educator	NOUN
ajbspi-35950	24	12	,	,	PUNCT
ajbspi-35950	24	13	providing	provide	VERB
ajbspi-35950	24	14	training	training	NOUN
ajbspi-35950	24	15	to	to	ADP
ajbspi-35950	24	16	medical	medical	ADJ
ajbspi-35950	24	17	students	student	NOUN
ajbspi-35950	24	18	,	,	PUNCT
ajbspi-35950	24	19	residents	resident	NOUN
ajbspi-35950	24	20	,	,	PUNCT
ajbspi-35950	24	21	and	and	CCONJ
ajbspi-35950	24	22	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	ADJ
ajbspi-35950	24	23	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	NOUN
ajbspi-35950	24	24	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-35950	24	25	volume	volume	NOUN
ajbspi-35950	24	26	04	04	NUM
ajbspi-35950	24	27	issue	issue	NOUN
ajbspi-35950	24	28	06	06	NUM
ajbspi-35950	24	29	-	-	SYM
ajbspi-35950	24	30	2024	2024	NUM
ajbspi-35950	24	31	10	10	NUM
ajbspi-35950	24	32	american	american	ADJ
ajbspi-35950	24	33	journal	journal	PROPN
ajbspi-35950	24	34	of	of	ADP
ajbspi-35950	24	35	biomedical	biomedical	PROPN
ajbspi-35950	24	36	science	science	PROPN
ajbspi-35950	24	37	&	&	CCONJ
ajbspi-35950	24	38	pharmaceutical	pharmaceutical	PROPN
ajbspi-35950	24	39	innovation	innovation	NOUN
ajbspi-35950	24	40	(	(	PUNCT
ajbspi-35950	24	41	issn	issn	PROPN
ajbspi-35950	24	42	–	–	PUNCT
ajbspi-35950	24	43	2771	2771	NUM
ajbspi-35950	24	44	-	-	SYM
ajbspi-35950	24	45	2753	2753	NUM
ajbspi-35950	24	46	)	)	PUNCT
ajbspi-35950	24	47	volume	volume	NOUN
ajbspi-35950	24	48	04	04	NUM
ajbspi-35950	24	49	issue	issue	NOUN
ajbspi-35950	24	50	06	06	NUM
ajbspi-35950	24	51	pages	page	NOUN
ajbspi-35950	24	52	:	:	PUNCT
ajbspi-35950	24	53	8	8	NUM
ajbspi-35950	24	54	-	-	SYM
ajbspi-35950	24	55	12	12	NUM
ajbspi-35950	24	56	oclc	oclc	PROPN
ajbspi-35950	24	57	–	–	PUNCT
ajbspi-35950	24	58	1121105677	1121105677	NUM
ajbspi-35950	24	59	publisher	publisher	NOUN
ajbspi-35950	24	60	:	:	PUNCT
ajbspi-35950	24	61	oscar	oscar	NOUN
ajbspi-35950	24	62	publishing	publishing	NOUN
ajbspi-35950	24	63	services	service	NOUN
ajbspi-35950	24	64	servi	servi	PROPN
ajbspi-35950	24	65	healthcare	healthcare	PROPN
ajbspi-35950	24	66	professionals	professional	NOUN
ajbspi-35950	24	67	.	.	PUNCT
ajbspi-35950	25	1	their	their	PRON
ajbspi-35950	25	2	teaching	teaching	NOUN
ajbspi-35950	25	3	ensures	ensure	VERB
ajbspi-35950	25	4	that	that	SCONJ
ajbspi-35950	25	5	the	the	DET
ajbspi-35950	25	6	next	next	ADJ
ajbspi-35950	25	7	generation	generation	NOUN
ajbspi-35950	25	8	of	of	ADP
ajbspi-35950	25	9	healthcare	healthcare	NOUN
ajbspi-35950	25	10	providers	provider	NOUN
ajbspi-35950	25	11	understands	understand	VERB
ajbspi-35950	25	12	the	the	DET
ajbspi-35950	25	13	principles	principle	NOUN
ajbspi-35950	25	14	of	of	ADP
ajbspi-35950	25	15	rational	rational	ADJ
ajbspi-35950	25	16	drug	drug	NOUN
ajbspi-35950	25	17	use	use	NOUN
ajbspi-35950	25	18	,	,	PUNCT
ajbspi-35950	25	19	fostering	foster	VERB
ajbspi-35950	25	20	a	a	DET
ajbspi-35950	25	21	culture	culture	NOUN
ajbspi-35950	25	22	of	of	ADP
ajbspi-35950	25	23	evidence	evidence	NOUN
ajbspi-35950	25	24	-	-	PUNCT
ajbspi-35950	25	25	based	base	VERB
ajbspi-35950	25	26	medicine	medicine	NOUN
ajbspi-35950	25	27	.	.	PUNCT
ajbspi-35950	26	1	5	5	X
ajbspi-35950	26	2	.	.	X
ajbspi-35950	26	3	clinical	clinical	ADJ
ajbspi-35950	26	4	research	research	NOUN
ajbspi-35950	26	5	and	and	CCONJ
ajbspi-35950	26	6	innovations	innovation	NOUN
ajbspi-35950	26	7	:	:	PUNCT
ajbspi-35950	26	8	beyond	beyond	ADP
ajbspi-35950	26	9	drug	drug	NOUN
ajbspi-35950	26	10	development	development	NOUN
ajbspi-35950	26	11	,	,	PUNCT
ajbspi-35950	26	12	clinical	clinical	ADJ
ajbspi-35950	26	13	pharmacologists	pharmacologist	NOUN
ajbspi-35950	26	14	conduct	conduct	VERB
ajbspi-35950	26	15	research	research	NOUN
ajbspi-35950	26	16	to	to	PART
ajbspi-35950	26	17	uncover	uncover	VERB
ajbspi-35950	26	18	new	new	ADJ
ajbspi-35950	26	19	therapeutic	therapeutic	ADJ
ajbspi-35950	26	20	targets	target	NOUN
ajbspi-35950	26	21	,	,	PUNCT
ajbspi-35950	26	22	understand	understand	VERB
ajbspi-35950	26	23	disease	disease	NOUN
ajbspi-35950	26	24	mechanisms	mechanism	NOUN
ajbspi-35950	26	25	and	and	CCONJ
ajbspi-35950	26	26	develop	develop	VERB
ajbspi-35950	26	27	novel	novel	ADJ
ajbspi-35950	26	28	treatment	treatment	NOUN
ajbspi-35950	26	29	strategies	strategy	NOUN
ajbspi-35950	26	30	.	.	PUNCT
ajbspi-35950	27	1	they	they	PRON
ajbspi-35950	27	2	also	also	ADV
ajbspi-35950	27	3	explore	explore	VERB
ajbspi-35950	27	4	innovative	innovative	ADJ
ajbspi-35950	27	5	drug	drug	NOUN
ajbspi-35950	27	6	delivery	delivery	NOUN
ajbspi-35950	27	7	systems	system	NOUN
ajbspi-35950	27	8	and	and	CCONJ
ajbspi-35950	27	9	formulations	formulation	NOUN
ajbspi-35950	27	10	that	that	PRON
ajbspi-35950	27	11	can	can	AUX
ajbspi-35950	27	12	improve	improve	VERB
ajbspi-35950	27	13	patient	patient	ADJ
ajbspi-35950	27	14	compliance	compliance	NOUN
ajbspi-35950	27	15	and	and	CCONJ
ajbspi-35950	27	16	outcomes	outcome	NOUN
ajbspi-35950	27	17	.	.	PUNCT
ajbspi-35950	28	1	notable	notable	ADJ
ajbspi-35950	28	2	achievements	achievement	NOUN
ajbspi-35950	28	3	1	1	NUM
ajbspi-35950	28	4	.	.	PUNCT
ajbspi-35950	28	5	precision	precision	NOUN
ajbspi-35950	28	6	medicine	medicine	NOUN
ajbspi-35950	28	7	:	:	PUNCT
ajbspi-35950	28	8	advances	advance	NOUN
ajbspi-35950	28	9	in	in	ADP
ajbspi-35950	28	10	genomics	genomic	NOUN
ajbspi-35950	28	11	and	and	CCONJ
ajbspi-35950	28	12	pharmacogenomics	pharmacogenomic	NOUN
ajbspi-35950	28	13	have	have	AUX
ajbspi-35950	28	14	allowed	allow	VERB
ajbspi-35950	28	15	clinical	clinical	ADJ
ajbspi-35950	28	16	pharmacologists	pharmacologist	NOUN
ajbspi-35950	28	17	to	to	PART
ajbspi-35950	28	18	develop	develop	VERB
ajbspi-35950	28	19	precision	precision	NOUN
ajbspi-35950	28	20	medicine	medicine	NOUN
ajbspi-35950	28	21	approaches	approach	NOUN
ajbspi-35950	28	22	.	.	PUNCT
ajbspi-35950	29	1	these	these	DET
ajbspi-35950	29	2	strategies	strategy	NOUN
ajbspi-35950	29	3	use	use	VERB
ajbspi-35950	29	4	genetic	genetic	ADJ
ajbspi-35950	29	5	information	information	NOUN
ajbspi-35950	29	6	to	to	PART
ajbspi-35950	29	7	predict	predict	VERB
ajbspi-35950	29	8	individual	individual	ADJ
ajbspi-35950	29	9	responses	response	NOUN
ajbspi-35950	29	10	to	to	ADP
ajbspi-35950	29	11	drugs	drug	NOUN
ajbspi-35950	29	12	,	,	PUNCT
ajbspi-35950	29	13	optimizing	optimize	VERB
ajbspi-35950	29	14	therapy	therapy	NOUN
ajbspi-35950	29	15	and	and	CCONJ
ajbspi-35950	29	16	reducing	reduce	VERB
ajbspi-35950	29	17	the	the	DET
ajbspi-35950	29	18	risk	risk	NOUN
ajbspi-35950	29	19	of	of	ADP
ajbspi-35950	29	20	adverse	adverse	ADJ
ajbspi-35950	29	21	effects	effect	NOUN
ajbspi-35950	29	22	.	.	PUNCT
ajbspi-35950	30	1	2	2	X
ajbspi-35950	30	2	.	.	X
ajbspi-35950	30	3	drug	drug	NOUN
ajbspi-35950	30	4	safety	safety	NOUN
ajbspi-35950	30	5	and	and	CCONJ
ajbspi-35950	30	6	pharmacovigilance	pharmacovigilance	NOUN
ajbspi-35950	30	7	:	:	PUNCT
ajbspi-35950	30	8	the	the	DET
ajbspi-35950	30	9	field	field	NOUN
ajbspi-35950	30	10	has	have	AUX
ajbspi-35950	30	11	made	make	VERB
ajbspi-35950	30	12	significant	significant	ADJ
ajbspi-35950	30	13	strides	stride	NOUN
ajbspi-35950	30	14	in	in	ADP
ajbspi-35950	30	15	detecting	detect	VERB
ajbspi-35950	30	16	,	,	PUNCT
ajbspi-35950	30	17	assessing	assess	VERB
ajbspi-35950	30	18	,	,	PUNCT
ajbspi-35950	30	19	and	and	CCONJ
ajbspi-35950	30	20	preventing	prevent	VERB
ajbspi-35950	30	21	adverse	adverse	ADJ
ajbspi-35950	30	22	drug	drug	NOUN
ajbspi-35950	30	23	reactions	reaction	NOUN
ajbspi-35950	30	24	.	.	PUNCT
ajbspi-35950	31	1	innovations	innovation	NOUN
ajbspi-35950	31	2	in	in	ADP
ajbspi-35950	31	3	data	datum	NOUN
ajbspi-35950	31	4	analytics	analytic	NOUN
ajbspi-35950	31	5	and	and	CCONJ
ajbspi-35950	31	6	real	real	ADJ
ajbspi-35950	31	7	-	-	PUNCT
ajbspi-35950	31	8	world	world	NOUN
ajbspi-35950	31	9	evidence	evidence	NOUN
ajbspi-35950	31	10	collection	collection	NOUN
ajbspi-35950	31	11	have	have	AUX
ajbspi-35950	31	12	enhanced	enhance	VERB
ajbspi-35950	31	13	pharmacovigilance	pharmacovigilance	NOUN
ajbspi-35950	31	14	systems	system	NOUN
ajbspi-35950	31	15	,	,	PUNCT
ajbspi-35950	31	16	ensuring	ensure	VERB
ajbspi-35950	31	17	the	the	DET
ajbspi-35950	31	18	safety	safety	NOUN
ajbspi-35950	31	19	of	of	ADP
ajbspi-35950	31	20	drugs	drug	NOUN
ajbspi-35950	31	21	even	even	ADV
ajbspi-35950	31	22	after	after	SCONJ
ajbspi-35950	31	23	they	they	PRON
ajbspi-35950	31	24	reach	reach	VERB
ajbspi-35950	31	25	the	the	DET
ajbspi-35950	31	26	market	market	NOUN
ajbspi-35950	31	27	.	.	PUNCT
ajbspi-35950	32	1	3	3	X
ajbspi-35950	32	2	.	.	X
ajbspi-35950	32	3	chronic	chronic	ADJ
ajbspi-35950	32	4	disease	disease	NOUN
ajbspi-35950	32	5	management	management	NOUN
ajbspi-35950	32	6	:	:	PUNCT
ajbspi-35950	32	7	clinical	clinical	ADJ
ajbspi-35950	32	8	pharmacology	pharmacology	NOUN
ajbspi-35950	32	9	has	have	AUX
ajbspi-35950	32	10	been	be	AUX
ajbspi-35950	32	11	instrumental	instrumental	ADJ
ajbspi-35950	32	12	in	in	ADP
ajbspi-35950	32	13	developing	develop	VERB
ajbspi-35950	32	14	effective	effective	ADJ
ajbspi-35950	32	15	treatments	treatment	NOUN
ajbspi-35950	32	16	for	for	ADP
ajbspi-35950	32	17	chronic	chronic	ADJ
ajbspi-35950	32	18	diseases	disease	NOUN
ajbspi-35950	32	19	such	such	ADJ
ajbspi-35950	32	20	as	as	ADP
ajbspi-35950	32	21	hypertension	hypertension	NOUN
ajbspi-35950	32	22	,	,	PUNCT
ajbspi-35950	32	23	diabetes	diabetes	NOUN
ajbspi-35950	32	24	,	,	PUNCT
ajbspi-35950	32	25	and	and	CCONJ
ajbspi-35950	32	26	cancer	cancer	NOUN
ajbspi-35950	32	27	.	.	PUNCT
ajbspi-35950	33	1	these	these	DET
ajbspi-35950	33	2	advancements	advancement	NOUN
ajbspi-35950	33	3	have	have	AUX
ajbspi-35950	33	4	significantly	significantly	ADV
ajbspi-35950	33	5	improved	improve	VERB
ajbspi-35950	33	6	patient	patient	ADJ
ajbspi-35950	33	7	prognosis	prognosis	NOUN
ajbspi-35950	33	8	and	and	CCONJ
ajbspi-35950	33	9	quality	quality	NOUN
ajbspi-35950	33	10	of	of	ADP
ajbspi-35950	33	11	life	life	NOUN
ajbspi-35950	33	12	.	.	PUNCT
ajbspi-35950	34	1	4	4	X
ajbspi-35950	34	2	.	.	X
ajbspi-35950	34	3	improved	improve	VERB
ajbspi-35950	34	4	therapeutic	therapeutic	ADJ
ajbspi-35950	34	5	outcomes	outcome	NOUN
ajbspi-35950	34	6	:	:	PUNCT
ajbspi-35950	34	7	rigorous	rigorous	ADJ
ajbspi-35950	34	8	clinical	clinical	ADJ
ajbspi-35950	34	9	trials	trial	NOUN
ajbspi-35950	34	10	and	and	CCONJ
ajbspi-35950	34	11	evidence	evidence	NOUN
ajbspi-35950	34	12	-	-	PUNCT
ajbspi-35950	34	13	based	base	VERB
ajbspi-35950	34	14	guidelines	guideline	NOUN
ajbspi-35950	34	15	have	have	AUX
ajbspi-35950	34	16	led	lead	VERB
ajbspi-35950	34	17	to	to	ADP
ajbspi-35950	34	18	the	the	DET
ajbspi-35950	34	19	optimization	optimization	NOUN
ajbspi-35950	34	20	of	of	ADP
ajbspi-35950	34	21	therapeutic	therapeutic	ADJ
ajbspi-35950	34	22	regimens	regimen	NOUN
ajbspi-35950	34	23	.	.	PUNCT
ajbspi-35950	35	1	this	this	PRON
ajbspi-35950	35	2	has	have	AUX
ajbspi-35950	35	3	resulted	result	VERB
ajbspi-35950	35	4	in	in	ADP
ajbspi-35950	35	5	better	well	ADJ
ajbspi-35950	35	6	patient	patient	ADJ
ajbspi-35950	35	7	outcomes	outcome	NOUN
ajbspi-35950	35	8	,	,	PUNCT
ajbspi-35950	35	9	particularly	particularly	ADV
ajbspi-35950	35	10	in	in	ADP
ajbspi-35950	35	11	the	the	DET
ajbspi-35950	35	12	management	management	NOUN
ajbspi-35950	35	13	of	of	ADP
ajbspi-35950	35	14	complex	complex	ADJ
ajbspi-35950	35	15	conditions	condition	NOUN
ajbspi-35950	35	16	like	like	ADP
ajbspi-35950	35	17	hiv	hiv	PROPN
ajbspi-35950	35	18	/	/	SYM
ajbspi-35950	35	19	aids	aids	PROPN
ajbspi-35950	35	20	,	,	PUNCT
ajbspi-35950	35	21	cardiovascular	cardiovascular	ADJ
ajbspi-35950	35	22	diseases	disease	NOUN
ajbspi-35950	35	23	,	,	PUNCT
ajbspi-35950	35	24	and	and	CCONJ
ajbspi-35950	35	25	autoimmune	autoimmune	ADJ
ajbspi-35950	35	26	disorders	disorder	NOUN
ajbspi-35950	35	27	.	.	PUNCT
ajbspi-35950	36	1	future	future	ADJ
ajbspi-35950	36	2	directions	direction	NOUN
ajbspi-35950	36	3	the	the	DET
ajbspi-35950	36	4	future	future	NOUN
ajbspi-35950	36	5	of	of	ADP
ajbspi-35950	36	6	clinical	clinical	ADJ
ajbspi-35950	36	7	pharmacology	pharmacology	NOUN
ajbspi-35950	36	8	holds	hold	VERB
ajbspi-35950	36	9	exciting	exciting	ADJ
ajbspi-35950	36	10	prospects	prospect	NOUN
ajbspi-35950	36	11	.	.	PUNCT
ajbspi-35950	37	1	areas	area	NOUN
ajbspi-35950	37	2	such	such	ADJ
ajbspi-35950	37	3	as	as	ADP
ajbspi-35950	37	4	digital	digital	ADJ
ajbspi-35950	37	5	health	health	NOUN
ajbspi-35950	37	6	,	,	PUNCT
ajbspi-35950	37	7	artificial	artificial	ADJ
ajbspi-35950	37	8	intelligence	intelligence	NOUN
ajbspi-35950	37	9	,	,	PUNCT
ajbspi-35950	37	10	and	and	CCONJ
ajbspi-35950	37	11	real	real	ADJ
ajbspi-35950	37	12	-	-	PUNCT
ajbspi-35950	37	13	world	world	NOUN
ajbspi-35950	37	14	evidence	evidence	NOUN
ajbspi-35950	37	15	are	be	AUX
ajbspi-35950	37	16	poised	poise	VERB
ajbspi-35950	37	17	to	to	PART
ajbspi-35950	37	18	revolutionize	revolutionize	VERB
ajbspi-35950	37	19	drug	drug	NOUN
ajbspi-35950	37	20	development	development	NOUN
ajbspi-35950	37	21	and	and	CCONJ
ajbspi-35950	37	22	patient	patient	ADJ
ajbspi-35950	37	23	care	care	NOUN
ajbspi-35950	37	24	.	.	PUNCT
ajbspi-35950	38	1	telemedicine	telemedicine	NOUN
ajbspi-35950	38	2	,	,	PUNCT
ajbspi-35950	38	3	electronic	electronic	ADJ
ajbspi-35950	38	4	health	health	NOUN
ajbspi-35950	38	5	records	record	NOUN
ajbspi-35950	38	6	,	,	PUNCT
ajbspi-35950	38	7	and	and	CCONJ
ajbspi-35950	38	8	wearable	wearable	ADJ
ajbspi-35950	38	9	devices	device	NOUN
ajbspi-35950	38	10	offer	offer	VERB
ajbspi-35950	38	11	new	new	ADJ
ajbspi-35950	38	12	opportunities	opportunity	NOUN
ajbspi-35950	38	13	for	for	ADP
ajbspi-35950	38	14	remote	remote	ADJ
ajbspi-35950	38	15	monitoring	monitoring	NOUN
ajbspi-35950	38	16	and	and	CCONJ
ajbspi-35950	38	17	personalized	personalized	ADJ
ajbspi-35950	38	18	treatment	treatment	NOUN
ajbspi-35950	38	19	adjustments	adjustment	NOUN
ajbspi-35950	38	20	.	.	PUNCT
ajbspi-35950	39	1	moreover	moreover	ADV
ajbspi-35950	39	2	,	,	PUNCT
ajbspi-35950	39	3	the	the	DET
ajbspi-35950	39	4	ongoing	ongoing	ADJ
ajbspi-35950	39	5	integration	integration	NOUN
ajbspi-35950	39	6	of	of	ADP
ajbspi-35950	39	7	pharmacogenomics	pharmacogenomic	NOUN
ajbspi-35950	39	8	into	into	ADP
ajbspi-35950	39	9	clinical	clinical	ADJ
ajbspi-35950	39	10	practice	practice	NOUN
ajbspi-35950	39	11	promises	promise	NOUN
ajbspi-35950	39	12	to	to	PART
ajbspi-35950	39	13	further	far	ADV
ajbspi-35950	39	14	refine	refine	VERB
ajbspi-35950	39	15	drug	drug	NOUN
ajbspi-35950	39	16	therapy	therapy	NOUN
ajbspi-35950	39	17	,	,	PUNCT
ajbspi-35950	39	18	reducing	reduce	VERB
ajbspi-35950	39	19	trial	trial	NOUN
ajbspi-35950	39	20	-	-	PUNCT
ajbspi-35950	39	21	and	and	CCONJ
ajbspi-35950	39	22	-	-	PUNCT
ajbspi-35950	39	23	error	error	NOUN
ajbspi-35950	39	24	prescribing	prescribing	NOUN
ajbspi-35950	39	25	and	and	CCONJ
ajbspi-35950	39	26	enhancing	enhance	VERB
ajbspi-35950	39	27	treatment	treatment	NOUN
ajbspi-35950	39	28	efficacy	efficacy	NOUN
ajbspi-35950	39	29	.	.	PUNCT
ajbspi-35950	40	1	advances	advance	NOUN
ajbspi-35950	40	2	in	in	ADP
ajbspi-35950	40	3	biotechnology	biotechnology	NOUN
ajbspi-35950	40	4	,	,	PUNCT
ajbspi-35950	40	5	including	include	VERB
ajbspi-35950	40	6	gene	gene	NOUN
ajbspi-35950	40	7	therapies	therapy	NOUN
ajbspi-35950	40	8	and	and	CCONJ
ajbspi-35950	40	9	personalized	personalized	ADJ
ajbspi-35950	40	10	vaccines	vaccine	NOUN
ajbspi-35950	40	11	,	,	PUNCT
ajbspi-35950	40	12	are	be	AUX
ajbspi-35950	40	13	likely	likely	ADJ
ajbspi-35950	40	14	to	to	PART
ajbspi-35950	40	15	expand	expand	VERB
ajbspi-35950	40	16	the	the	DET
ajbspi-35950	40	17	therapeutic	therapeutic	ADJ
ajbspi-35950	40	18	arsenal	arsenal	NOUN
ajbspi-35950	40	19	available	available	ADJ
ajbspi-35950	40	20	to	to	ADP
ajbspi-35950	40	21	clinical	clinical	ADJ
ajbspi-35950	40	22	pharmacologists	pharmacologist	NOUN
ajbspi-35950	40	23	.	.	PUNCT
ajbspi-35950	41	1	conclusion	conclusion	NOUN
ajbspi-35950	41	2	clinical	clinical	ADJ
ajbspi-35950	41	3	pharmacology	pharmacology	NOUN
ajbspi-35950	41	4	is	be	AUX
ajbspi-35950	41	5	a	a	DET
ajbspi-35950	41	6	dynamic	dynamic	ADJ
ajbspi-35950	41	7	and	and	CCONJ
ajbspi-35950	41	8	essential	essential	ADJ
ajbspi-35950	41	9	field	field	NOUN
ajbspi-35950	41	10	that	that	PRON
ajbspi-35950	41	11	bridges	bridge	VERB
ajbspi-35950	41	12	the	the	DET
ajbspi-35950	41	13	gap	gap	NOUN
ajbspi-35950	41	14	between	between	ADP
ajbspi-35950	41	15	drug	drug	NOUN
ajbspi-35950	41	16	discovery	discovery	NOUN
ajbspi-35950	41	17	and	and	CCONJ
ajbspi-35950	41	18	patient	patient	ADJ
ajbspi-35950	41	19	care	care	NOUN
ajbspi-35950	41	20	.	.	PUNCT
ajbspi-35950	42	1	through	through	ADP
ajbspi-35950	42	2	rigorous	rigorous	ADJ
ajbspi-35950	42	3	research	research	NOUN
ajbspi-35950	42	4	,	,	PUNCT
ajbspi-35950	42	5	clinical	clinical	ADJ
ajbspi-35950	42	6	trials	trial	NOUN
ajbspi-35950	42	7	,	,	PUNCT
ajbspi-35950	42	8	and	and	CCONJ
ajbspi-35950	42	9	evidence	evidence	NOUN
ajbspi-35950	42	10	-	-	PUNCT
ajbspi-35950	42	11	based	base	VERB
ajbspi-35950	42	12	practice	practice	NOUN
ajbspi-35950	42	13	,	,	PUNCT
ajbspi-35950	42	14	clinical	clinical	ADJ
ajbspi-35950	42	15	pharmacologists	pharmacologist	NOUN
ajbspi-35950	42	16	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	VERB
ajbspi-35950	42	17	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-35950	42	18	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-35950	42	19	volume	volume	NOUN
ajbspi-35950	42	20	04	04	NUM
ajbspi-35950	42	21	issue	issue	NOUN
ajbspi-35950	42	22	06	06	NUM
ajbspi-35950	42	23	-	-	SYM
ajbspi-35950	42	24	2024	2024	NUM
ajbspi-35950	42	25	11	11	NUM
ajbspi-35950	42	26	american	american	ADJ
ajbspi-35950	42	27	journal	journal	PROPN
ajbspi-35950	42	28	of	of	ADP
ajbspi-35950	42	29	biomedical	biomedical	PROPN
ajbspi-35950	42	30	science	science	PROPN
ajbspi-35950	42	31	&	&	CCONJ
ajbspi-35950	42	32	pharmaceutical	pharmaceutical	PROPN
ajbspi-35950	42	33	innovation	innovation	NOUN
ajbspi-35950	42	34	(	(	PUNCT
ajbspi-35950	42	35	issn	issn	PROPN
ajbspi-35950	42	36	–	–	PUNCT
ajbspi-35950	42	37	2771	2771	NUM
ajbspi-35950	42	38	-	-	SYM
ajbspi-35950	42	39	2753	2753	NUM
ajbspi-35950	42	40	)	)	PUNCT
ajbspi-35950	42	41	volume	volume	NOUN
ajbspi-35950	42	42	04	04	NUM
ajbspi-35950	43	1	issue	issue	NOUN
ajbspi-35950	43	2	06	06	NUM
ajbspi-35950	43	3	pages	page	NOUN
ajbspi-35950	43	4	:	:	PUNCT
ajbspi-35950	43	5	8	8	NUM
ajbspi-35950	43	6	-	-	SYM
ajbspi-35950	43	7	12	12	NUM
ajbspi-35950	43	8	oclc	oclc	PROPN
ajbspi-35950	43	9	–	–	PUNCT
ajbspi-35950	43	10	1121105677	1121105677	NUM
ajbspi-35950	43	11	publisher	publisher	NOUN
ajbspi-35950	43	12	:	:	PUNCT
ajbspi-35950	43	13	oscar	oscar	NOUN
ajbspi-35950	43	14	publishing	publishing	NOUN
ajbspi-35950	43	15	services	service	NOUN
ajbspi-35950	43	16	servi	servi	PROPN
ajbspi-35950	43	17	have	have	AUX
ajbspi-35950	43	18	significantly	significantly	ADV
ajbspi-35950	43	19	advanced	advance	VERB
ajbspi-35950	43	20	our	our	PRON
ajbspi-35950	43	21	understanding	understanding	NOUN
ajbspi-35950	43	22	of	of	ADP
ajbspi-35950	43	23	drug	drug	NOUN
ajbspi-35950	43	24	therapy	therapy	NOUN
ajbspi-35950	43	25	,	,	PUNCT
ajbspi-35950	43	26	leading	lead	VERB
ajbspi-35950	43	27	to	to	ADP
ajbspi-35950	43	28	improved	improve	VERB
ajbspi-35950	43	29	patient	patient	ADJ
ajbspi-35950	43	30	outcomes	outcome	NOUN
ajbspi-35950	43	31	and	and	CCONJ
ajbspi-35950	43	32	public	public	ADJ
ajbspi-35950	43	33	health	health	NOUN
ajbspi-35950	43	34	.	.	PUNCT
ajbspi-35950	44	1	as	as	SCONJ
ajbspi-35950	44	2	the	the	DET
ajbspi-35950	44	3	field	field	NOUN
ajbspi-35950	44	4	continues	continue	VERB
ajbspi-35950	44	5	to	to	PART
ajbspi-35950	44	6	evolve	evolve	VERB
ajbspi-35950	44	7	,	,	PUNCT
ajbspi-35950	44	8	its	its	PRON
ajbspi-35950	44	9	contributions	contribution	NOUN
ajbspi-35950	44	10	will	will	AUX
ajbspi-35950	44	11	be	be	AUX
ajbspi-35950	44	12	pivotal	pivotal	ADJ
ajbspi-35950	44	13	in	in	ADP
ajbspi-35950	44	14	addressing	address	VERB
ajbspi-35950	44	15	the	the	DET
ajbspi-35950	44	16	complex	complex	ADJ
ajbspi-35950	44	17	healthcare	healthcare	NOUN
ajbspi-35950	44	18	challenges	challenge	NOUN
ajbspi-35950	44	19	of	of	ADP
ajbspi-35950	44	20	the	the	DET
ajbspi-35950	44	21	future	future	NOUN
ajbspi-35950	44	22	.	.	PUNCT
ajbspi-35950	45	1	references	reference	NOUN
ajbspi-35950	45	2	1	1	NUM
ajbspi-35950	45	3	.	.	PUNCT
ajbspi-35950	45	4	johnson	johnson	PROPN
ajbspi-35950	45	5	m.	m.	PROPN
ajbspi-35950	45	6	et	et	PROPN
ajbspi-35950	45	7	al	al	PROPN
ajbspi-35950	45	8	.	.	PUNCT
ajbspi-35950	46	1	the	the	DET
ajbspi-35950	46	2	potential	potential	NOUN
ajbspi-35950	46	3	and	and	CCONJ
ajbspi-35950	46	4	pitfalls	pitfall	NOUN
ajbspi-35950	46	5	of	of	ADP
ajbspi-35950	46	6	artificial	artificial	ADJ
ajbspi-35950	46	7	intelligence	intelligence	NOUN
ajbspi-35950	46	8	in	in	ADP
ajbspi-35950	46	9	clinical	clinical	ADJ
ajbspi-35950	46	10	pharmacology	pharmacology	NOUN
ajbspi-35950	46	11	//cpt	//cpt	NOUN
ajbspi-35950	46	12	:	:	PUNCT
ajbspi-35950	46	13	pharmacometrics	pharmacometrics	PROPN
ajbspi-35950	46	14	&	&	CCONJ
ajbspi-35950	46	15	systems	systems	PROPN
ajbspi-35950	46	16	pharmacology	pharmacology	NOUN
ajbspi-35950	46	17	.	.	PUNCT
ajbspi-35950	46	18	–	–	PUNCT
ajbspi-35950	46	19	2023	2023	NUM
ajbspi-35950	46	20	.	.	PUNCT
ajbspi-35950	47	1	–	–	PUNCT
ajbspi-35950	47	2	т	т	X
ajbspi-35950	47	3	.	.	PROPN
ajbspi-35950	47	4	12	12	NUM
ajbspi-35950	47	5	.	.	PUNCT
ajbspi-35950	47	6	–	–	PUNCT
ajbspi-35950	47	7	№	№	NOUN
ajbspi-35950	47	8	.	.	PUNCT
ajbspi-35950	48	1	3	3	X
ajbspi-35950	48	2	.	.	X
ajbspi-35950	48	3	–	–	PUNCT
ajbspi-35950	48	4	с	с	NOUN
ajbspi-35950	48	5	.	.	PROPN
ajbspi-35950	48	6	279	279	NUM
ajbspi-35950	48	7	-	-	SYM
ajbspi-35950	48	8	284	284	NUM
ajbspi-35950	48	9	.	.	PUNCT
ajbspi-35950	49	1	2	2	NUM
ajbspi-35950	49	2	.	.	X
ajbspi-35950	49	3	fournier	fournier	PROPN
ajbspi-35950	49	4	a.	a.	PROPN
ajbspi-35950	49	5	et	et	PROPN
ajbspi-35950	49	6	al	al	PROPN
ajbspi-35950	49	7	.	.	PUNCT
ajbspi-35950	50	1	assessing	assess	VERB
ajbspi-35950	50	2	the	the	DET
ajbspi-35950	50	3	applicability	applicability	NOUN
ajbspi-35950	50	4	and	and	CCONJ
ajbspi-35950	50	5	appropriateness	appropriateness	NOUN
ajbspi-35950	50	6	of	of	ADP
ajbspi-35950	50	7	chatgpt	chatgpt	NOUN
ajbspi-35950	50	8	in	in	ADP
ajbspi-35950	50	9	answering	answer	VERB
ajbspi-35950	50	10	clinical	clinical	ADJ
ajbspi-35950	50	11	pharmacy	pharmacy	NOUN
ajbspi-35950	50	12	questions	question	NOUN
ajbspi-35950	50	13	//annales	//annales	PUNCT
ajbspi-35950	50	14	pharmaceutiques	pharmaceutique	NOUN
ajbspi-35950	50	15	françaises	française	NOUN
ajbspi-35950	50	16	.	.	PUNCT
ajbspi-35950	51	1	–	–	PUNCT
ajbspi-35950	51	2	elsevier	elsevier	PROPN
ajbspi-35950	51	3	masson	masson	PROPN
ajbspi-35950	51	4	,	,	PUNCT
ajbspi-35950	51	5	2024	2024	NUM
ajbspi-35950	51	6	.	.	PUNCT
ajbspi-35950	52	1	–	–	PUNCT
ajbspi-35950	52	2	т	т	X
ajbspi-35950	52	3	.	.	NOUN
ajbspi-35950	52	4	82	82	NUM
ajbspi-35950	52	5	.	.	PUNCT
ajbspi-35950	52	6	–	–	PUNCT
ajbspi-35950	52	7	№	№	NOUN
ajbspi-35950	52	8	.	.	PUNCT
ajbspi-35950	53	1	3	3	X
ajbspi-35950	53	2	.	.	X
ajbspi-35950	53	3	–	–	PUNCT
ajbspi-35950	53	4	с	с	NOUN
ajbspi-35950	53	5	.	.	PUNCT
ajbspi-35950	54	1	507	507	NUM
ajbspi-35950	54	2	-	-	SYM
ajbspi-35950	54	3	513	513	NUM
ajbspi-35950	54	4	.	.	PUNCT
ajbspi-35950	55	1	3	3	NUM
ajbspi-35950	55	2	.	.	X
ajbspi-35950	55	3	muradova	muradova	PROPN
ajbspi-35950	55	4	r.	r.	PROPN
ajbspi-35950	55	5	the	the	DET
ajbspi-35950	55	6	need	need	NOUN
ajbspi-35950	55	7	for	for	ADP
ajbspi-35950	55	8	pharmacotherapy	pharmacotherapy	NOUN
ajbspi-35950	55	9	with	with	ADP
ajbspi-35950	55	10	vitamins	vitamin	NOUN
ajbspi-35950	55	11	//science	//science	PUNCT
ajbspi-35950	55	12	and	and	CCONJ
ajbspi-35950	55	13	innovation	innovation	NOUN
ajbspi-35950	55	14	.	.	PUNCT
ajbspi-35950	56	1	–	–	PUNCT
ajbspi-35950	56	2	2024	2024	NUM
ajbspi-35950	56	3	.	.	PUNCT
ajbspi-35950	57	1	–	–	PUNCT
ajbspi-35950	57	2	т	т	X
ajbspi-35950	57	3	.	.	NOUN
ajbspi-35950	57	4	3	3	NUM
ajbspi-35950	57	5	.	.	X
ajbspi-35950	57	6	–	–	PUNCT
ajbspi-35950	57	7	№	№	NOUN
ajbspi-35950	57	8	.	.	PUNCT
ajbspi-35950	58	1	d3	d3	PROPN
ajbspi-35950	58	2	.	.	PUNCT
ajbspi-35950	58	3	–	–	PUNCT
ajbspi-35950	59	1	с	с	NOUN
ajbspi-35950	59	2	.	.	PUNCT
ajbspi-35950	59	3	188	188	NUM
ajbspi-35950	59	4	-	-	SYM
ajbspi-35950	59	5	191	191	NUM
ajbspi-35950	59	6	.	.	PUNCT
ajbspi-35950	59	7	4	4	NUM
ajbspi-35950	59	8	.	.	X
ajbspi-35950	60	1	muradova	muradova	PROPN
ajbspi-35950	60	2	r.	r.	PROPN
ajbspi-35950	60	3	,	,	PUNCT
ajbspi-35950	60	4	haydarov	haydarov	PROPN
ajbspi-35950	60	5	m.	m.	NOUN
ajbspi-35950	60	6	multiple	multiple	ADJ
ajbspi-35950	60	7	organ	organ	NOUN
ajbspi-35950	60	8	failure	failure	NOUN
ajbspi-35950	60	9	in	in	ADP
ajbspi-35950	60	10	children	child	NOUN
ajbspi-35950	60	11	with	with	ADP
ajbspi-35950	60	12	burns	burn	NOUN
ajbspi-35950	60	13	//science	//science	NOUN
ajbspi-35950	60	14	and	and	CCONJ
ajbspi-35950	60	15	innovation	innovation	NOUN
ajbspi-35950	60	16	.	.	PUNCT
ajbspi-35950	60	17	–	–	PUNCT
ajbspi-35950	60	18	2023	2023	NUM
ajbspi-35950	60	19	.	.	PUNCT
ajbspi-35950	60	20	–	–	PUNCT
ajbspi-35950	60	21	т	т	X
ajbspi-35950	60	22	.	.	NOUN
ajbspi-35950	60	23	2	2	NUM
ajbspi-35950	60	24	.	.	X
ajbspi-35950	60	25	–	–	PUNCT
ajbspi-35950	60	26	№	№	NOUN
ajbspi-35950	60	27	.	.	PUNCT
ajbspi-35950	61	1	d2	d2	PROPN
ajbspi-35950	61	2	.	.	PUNCT
ajbspi-35950	61	3	–	–	PUNCT
ajbspi-35950	62	1	с	с	PROPN
ajbspi-35950	62	2	.	.	PROPN
ajbspi-35950	62	3	83	83	NUM
ajbspi-35950	62	4	-	-	SYM
ajbspi-35950	62	5	90	90	NUM
ajbspi-35950	62	6	.	.	PUNCT
ajbspi-35950	62	7	5	5	NUM
ajbspi-35950	62	8	.	.	X
ajbspi-35950	62	9	muradova	muradova	PROPN
ajbspi-35950	62	10	r.	r.	PROPN
ajbspi-35950	62	11	treatment	treatment	NOUN
ajbspi-35950	62	12	of	of	ADP
ajbspi-35950	62	13	burn	burn	NOUN
ajbspi-35950	62	14	sepsis	sepsis	NOUN
ajbspi-35950	62	15	against	against	ADP
ajbspi-35950	62	16	the	the	DET
ajbspi-35950	62	17	background	background	NOUN
ajbspi-35950	62	18	of	of	ADP
ajbspi-35950	62	19	multiple	multiple	ADJ
ajbspi-35950	62	20	organ	organ	NOUN
ajbspi-35950	62	21	failure	failure	NOUN
ajbspi-35950	62	22	in	in	ADP
ajbspi-35950	62	23	children	child	NOUN
ajbspi-35950	62	24	//science	//science	PUNCT
ajbspi-35950	62	25	and	and	CCONJ
ajbspi-35950	62	26	innovation	innovation	NOUN
ajbspi-35950	62	27	.	.	PUNCT
ajbspi-35950	63	1	–	–	PUNCT
ajbspi-35950	63	2	2023	2023	NUM
ajbspi-35950	63	3	.	.	PUNCT
ajbspi-35950	64	1	–	–	PUNCT
ajbspi-35950	64	2	т	т	X
ajbspi-35950	64	3	.	.	NOUN
ajbspi-35950	64	4	2	2	NUM
ajbspi-35950	64	5	.	.	X
ajbspi-35950	64	6	–	–	PUNCT
ajbspi-35950	64	7	№	№	NOUN
ajbspi-35950	64	8	.	.	PUNCT
ajbspi-35950	65	1	d2	d2	PROPN
ajbspi-35950	65	2	.	.	PUNCT
ajbspi-35950	65	3	–	–	PUNCT
ajbspi-35950	66	1	с	с	PROPN
ajbspi-35950	66	2	.	.	PROPN
ajbspi-35950	66	3	227	227	NUM
ajbspi-35950	66	4	-	-	SYM
ajbspi-35950	66	5	232	232	NUM
ajbspi-35950	66	6	.	.	NOUN
ajbspi-35950	66	7	6	6	NUM
ajbspi-35950	66	8	.	.	X
ajbspi-35950	66	9	ranchon	ranchon	PROPN
ajbspi-35950	66	10	f.	f.	PROPN
ajbspi-35950	66	11	et	et	PROPN
ajbspi-35950	66	12	al	al	PROPN
ajbspi-35950	66	13	.	.	PROPN
ajbspi-35950	66	14	development	development	NOUN
ajbspi-35950	66	15	of	of	ADP
ajbspi-35950	66	16	artificial	artificial	ADJ
ajbspi-35950	66	17	intelligence	intelligence	NOUN
ajbspi-35950	66	18	powered	power	VERB
ajbspi-35950	66	19	apps	app	NOUN
ajbspi-35950	66	20	and	and	CCONJ
ajbspi-35950	66	21	tools	tool	NOUN
ajbspi-35950	66	22	for	for	ADP
ajbspi-35950	66	23	clinical	clinical	ADJ
ajbspi-35950	66	24	pharmacy	pharmacy	NOUN
ajbspi-35950	66	25	services	service	NOUN
ajbspi-35950	66	26	:	:	PUNCT
ajbspi-35950	66	27	a	a	DET
ajbspi-35950	66	28	systematic	systematic	ADJ
ajbspi-35950	66	29	review	review	NOUN
ajbspi-35950	66	30	//international	//international	ADJ
ajbspi-35950	66	31	journal	journal	PROPN
ajbspi-35950	66	32	of	of	ADP
ajbspi-35950	66	33	medical	medical	ADJ
ajbspi-35950	66	34	informatics	informatic	NOUN
ajbspi-35950	66	35	.	.	PUNCT
ajbspi-35950	66	36	–	–	PUNCT
ajbspi-35950	66	37	2023	2023	NUM
ajbspi-35950	66	38	.	.	PUNCT
ajbspi-35950	67	1	–	–	PUNCT
ajbspi-35950	67	2	т	т	X
ajbspi-35950	67	3	.	.	PROPN
ajbspi-35950	67	4	172	172	NUM
ajbspi-35950	67	5	.	.	PUNCT
ajbspi-35950	67	6	–	–	PUNCT
ajbspi-35950	68	1	с	с	PROPN
ajbspi-35950	68	2	.	.	PROPN
ajbspi-35950	68	3	104983	104983	NUM
ajbspi-35950	68	4	.	.	PUNCT
ajbspi-35950	69	1	7	7	X
ajbspi-35950	69	2	.	.	X
ajbspi-35950	69	3	shahin	shahin	PROPN
ajbspi-35950	69	4	m.	m.	PROPN
ajbspi-35950	69	5	h.	h.	PROPN
ajbspi-35950	69	6	et	et	PROPN
ajbspi-35950	69	7	al	al	PROPN
ajbspi-35950	69	8	.	.	PUNCT
ajbspi-35950	69	9	artificial	artificial	ADJ
ajbspi-35950	69	10	intelligence	intelligence	NOUN
ajbspi-35950	69	11	:	:	PUNCT
ajbspi-35950	69	12	from	from	ADP
ajbspi-35950	69	13	buzzword	buzzword	NOUN
ajbspi-35950	69	14	to	to	ADP
ajbspi-35950	69	15	useful	useful	ADJ
ajbspi-35950	69	16	tool	tool	NOUN
ajbspi-35950	69	17	in	in	ADP
ajbspi-35950	69	18	clinical	clinical	ADJ
ajbspi-35950	69	19	pharmacology	pharmacology	NOUN
ajbspi-35950	69	20	//clinical	//clinical	PUNCT
ajbspi-35950	69	21	pharmacology	pharmacology	NOUN
ajbspi-35950	69	22	&	&	CCONJ
ajbspi-35950	69	23	therapeutics	therapeutic	NOUN
ajbspi-35950	69	24	.	.	PUNCT
ajbspi-35950	70	1	–	–	PUNCT
ajbspi-35950	70	2	2024	2024	NUM
ajbspi-35950	70	3	.	.	PUNCT
ajbspi-35950	71	1	–	–	PUNCT
ajbspi-35950	71	2	т	т	X
ajbspi-35950	71	3	.	.	NOUN
ajbspi-35950	71	4	115	115	NUM
ajbspi-35950	71	5	.	.	PUNCT
ajbspi-35950	72	1	–	–	PUNCT
ajbspi-35950	72	2	№	№	NOUN
ajbspi-35950	72	3	.	.	PUNCT
ajbspi-35950	73	1	4	4	NUM
ajbspi-35950	73	2	.	.	X
ajbspi-35950	73	3	–	–	PUNCT
ajbspi-35950	73	4	с	с	NOUN
ajbspi-35950	73	5	.	.	PUNCT
ajbspi-35950	74	1	698	698	NUM
ajbspi-35950	74	2	-	-	SYM
ajbspi-35950	74	3	709	709	NUM
ajbspi-35950	74	4	.	.	NOUN
ajbspi-35950	74	5	8	8	NUM
ajbspi-35950	74	6	.	.	PUNCT
ajbspi-35950	75	1	аскарова	аскарова	NOUN
ajbspi-35950	75	2	ф	ф	PRON
ajbspi-35950	75	3	.	.	PROPN
ajbspi-35950	75	4	,	,	PUNCT
ajbspi-35950	75	5	яхшиноров	яхшиноров	ADP
ajbspi-35950	75	6	и	и	PROPN
ajbspi-35950	75	7	.	.	PUNCT
ajbspi-35950	76	1	влияние	влияние	PROPN
ajbspi-35950	76	2	метаболических	метаболических	ADP
ajbspi-35950	76	3	изменений	изменений	PROPN
ajbspi-35950	76	4	на	на	PROPN
ajbspi-35950	76	5	сердечнососудистую	сердечнососудистую	PROPN
ajbspi-35950	76	6	систему	систему	VERB
ajbspi-35950	76	7	женщин	женщин	PROPN
ajbspi-35950	76	8	//евразийский	//евразийский	X
ajbspi-35950	76	9	журнал	журнал	PROPN
ajbspi-35950	76	10	медицинских	медицинских	PROPN
ajbspi-35950	76	11	и	и	PROPN
ajbspi-35950	76	12	естественных	естественных	PROPN
ajbspi-35950	76	13	наук	наук	NOUN
ajbspi-35950	76	14	.	.	PUNCT
ajbspi-35950	77	1	–	–	PUNCT
ajbspi-35950	77	2	2024	2024	NUM
ajbspi-35950	77	3	.	.	PUNCT
ajbspi-35950	78	1	–	–	PUNCT
ajbspi-35950	78	2	т	т	X
ajbspi-35950	78	3	.	.	NOUN
ajbspi-35950	78	4	4	4	NUM
ajbspi-35950	78	5	.	.	X
ajbspi-35950	78	6	–	–	PUNCT
ajbspi-35950	78	7	№	№	NOUN
ajbspi-35950	78	8	.	.	PUNCT
ajbspi-35950	79	1	4	4	NUM
ajbspi-35950	79	2	.	.	X
ajbspi-35950	79	3	–	–	PUNCT
ajbspi-35950	79	4	с	с	NOUN
ajbspi-35950	79	5	.	.	PROPN
ajbspi-35950	80	1	150	150	NUM
ajbspi-35950	80	2	-	-	SYM
ajbspi-35950	80	3	155	155	NUM
ajbspi-35950	80	4	.	.	NOUN
ajbspi-35950	80	5	9	9	NUM
ajbspi-35950	80	6	.	.	X
ajbspi-35950	80	7	аллазов	аллазов	PROPN
ajbspi-35950	81	1	с	с	PROPN
ajbspi-35950	81	2	.	.	PUNCT
ajbspi-35950	82	1	а	а	PROPN
ajbspi-35950	82	2	.	.	PROPN
ajbspi-35950	82	3	,	,	PUNCT
ajbspi-35950	82	4	кaмaлoв	кaмaлoв	VERB
ajbspi-35950	82	5	н	н	PRON
ajbspi-35950	82	6	.	.	PUNCT
ajbspi-35950	83	1	а	а	PROPN
ajbspi-35950	83	2	.	.	PROPN
ajbspi-35950	83	3	,	,	PUNCT
ajbspi-35950	83	4	мурадова	мурадова	VERB
ajbspi-35950	83	5	р	р	ADP
ajbspi-35950	83	6	.	.	PROPN
ajbspi-35950	83	7	р	р	PROPN
ajbspi-35950	83	8	.	.	PROPN
ajbspi-35950	83	9	жисткостные	жисткостные	NOUN
ajbspi-35950	83	10	объемные	объемные	NOUN
ajbspi-35950	83	11	образования	образования	NOUN
ajbspi-35950	83	12	почек	почек	NOUN
ajbspi-35950	83	13	(	(	PUNCT
ajbspi-35950	83	14	обзор	обзор	PROPN
ajbspi-35950	83	15	литературы	литературы	NOUN
ajbspi-35950	83	16	)	)	PUNCT
ajbspi-35950	83	17	//журнал	//журнал	PUNCT
ajbspi-35950	83	18	репродуктивного	репродуктивного	NOUN
ajbspi-35950	83	19	здоровья	здоровья	NOUN
ajbspi-35950	83	20	и	и	PROPN
ajbspi-35950	83	21	уронефрологических	уронефрологических	PROPN
ajbspi-35950	83	22	исследований	исследований	PROPN
ajbspi-35950	83	23	.	.	PUNCT
ajbspi-35950	84	1	–	–	PUNCT
ajbspi-35950	84	2	2021	2021	NUM
ajbspi-35950	84	3	.	.	PUNCT
ajbspi-35950	85	1	–	–	PUNCT
ajbspi-35950	85	2	т	т	X
ajbspi-35950	85	3	.	.	NOUN
ajbspi-35950	85	4	2	2	NUM
ajbspi-35950	85	5	.	.	X
ajbspi-35950	85	6	–	–	PUNCT
ajbspi-35950	85	7	№	№	NOUN
ajbspi-35950	85	8	.	.	NOUN
ajbspi-35950	86	1	1	1	NUM
ajbspi-35950	86	2	.	.	X
ajbspi-35950	86	3	10	10	NUM
ajbspi-35950	86	4	.	.	X
ajbspi-35950	86	5	мурадова	мурадова	NOUN
ajbspi-35950	86	6	р	р	ADP
ajbspi-35950	86	7	.	.	PROPN
ajbspi-35950	86	8	р	р	PROPN
ajbspi-35950	86	9	.	.	PROPN
ajbspi-35950	86	10	,	,	PUNCT
ajbspi-35950	86	11	хайдаров	хайдаров	PROPN
ajbspi-35950	86	12	м	м	NUM
ajbspi-35950	86	13	.	.	PUNCT
ajbspi-35950	87	1	м	м	X
ajbspi-35950	87	2	.	.	PUNCT
ajbspi-35950	87	3	клиникофармакологические	клиникофармакологические	PROPN
ajbspi-35950	87	4	аспекты	аспекты	PROPN
ajbspi-35950	87	5	применения	применения	PROPN
ajbspi-35950	87	6	гормональных	гормональных	PROPN
ajbspi-35950	87	7	препаратов	препаратов	PROPN
ajbspi-35950	87	8	в	в	PROPN
ajbspi-35950	87	9	офтальмологии	офтальмологии	PROPN
ajbspi-35950	87	10	//достижения	//достижения	PUNCT
ajbspi-35950	87	11	науки	науки	PROPN
ajbspi-35950	87	12	и	и	PROPN
ajbspi-35950	87	13	образования	образования	NOUN
ajbspi-35950	87	14	.	.	PUNCT
ajbspi-35950	88	1	–	–	PUNCT
ajbspi-35950	88	2	2021	2021	NUM
ajbspi-35950	88	3	.	.	PUNCT
ajbspi-35950	89	1	–	–	PUNCT
ajbspi-35950	89	2	№	№	NOUN
ajbspi-35950	89	3	.	.	NOUN
ajbspi-35950	90	1	3	3	NUM
ajbspi-35950	90	2	(	(	PUNCT
ajbspi-35950	90	3	75	75	NUM
ajbspi-35950	90	4	)	)	PUNCT
ajbspi-35950	90	5	.	.	PUNCT
ajbspi-35950	91	1	–	–	PUNCT
ajbspi-35950	91	2	с	с	NOUN
ajbspi-35950	91	3	.	.	PROPN
ajbspi-35950	91	4	100	100	NUM
ajbspi-35950	91	5	-	-	SYM
ajbspi-35950	91	6	102	102	NUM
ajbspi-35950	91	7	.	.	PUNCT
ajbspi-35950	92	1	11	11	NUM
ajbspi-35950	92	2	.	.	X
ajbspi-35950	92	3	мурадова	мурадова	VERB
ajbspi-35950	92	4	р	р	ADP
ajbspi-35950	92	5	.	.	PROPN
ajbspi-35950	92	6	р	р	PROPN
ajbspi-35950	92	7	.	.	PROPN
ajbspi-35950	92	8	,	,	PUNCT
ajbspi-35950	92	9	хайдаров	хайдаров	PROPN
ajbspi-35950	92	10	м	м	NUM
ajbspi-35950	92	11	.	.	PUNCT
ajbspi-35950	93	1	м	м	X
ajbspi-35950	93	2	.	.	PROPN
ajbspi-35950	93	3	,	,	PUNCT
ajbspi-35950	93	4	бегнаева	бегнаева	VERB
ajbspi-35950	93	5	м	м	X
ajbspi-35950	93	6	.	.	PUNCT
ajbspi-35950	94	1	у	у	X
ajbspi-35950	94	2	.	.	PUNCT
ajbspi-35950	94	3	современные	современные	PROPN
ajbspi-35950	94	4	клинико	клинико	PROPN
ajbspi-35950	94	5	-	-	PUNCT
ajbspi-35950	94	6	фармакологические	фармакологические	PROPN
ajbspi-35950	94	7	аспекты	аспекты	ADJ
ajbspi-35950	94	8	применения	применения	PROPN
ajbspi-35950	94	9	нефротоксичных	нефротоксичных	PROPN
ajbspi-35950	94	10	антибиотиков	антибиотиков	NOUN
ajbspi-35950	94	11	//достижения	//достижения	PUNCT
ajbspi-35950	94	12	науки	науки	PROPN
ajbspi-35950	94	13	и	и	PROPN
ajbspi-35950	94	14	образования	образования	NOUN
ajbspi-35950	94	15	.	.	PUNCT
ajbspi-35950	94	16	–	–	PUNCT
ajbspi-35950	94	17	2021	2021	NUM
ajbspi-35950	94	18	.	.	PUNCT
ajbspi-35950	95	1	–	–	PUNCT
ajbspi-35950	95	2	№	№	NOUN
ajbspi-35950	95	3	.	.	PUNCT
ajbspi-35950	96	1	3	3	X
ajbspi-35950	96	2	.	.	X
ajbspi-35950	96	3	–	–	PUNCT
ajbspi-35950	96	4	с	с	NOUN
ajbspi-35950	96	5	.	.	PROPN
ajbspi-35950	96	6	98	98	NUM
ajbspi-35950	96	7	-	-	SYM
ajbspi-35950	96	8	100	100	NUM
ajbspi-35950	96	9	.	.	PUNCT
ajbspi-35950	96	10	12	12	NUM
ajbspi-35950	96	11	.	.	PUNCT
ajbspi-35950	96	12	мурадова	мурадова	NOUN
ajbspi-35950	96	13	р	р	ADP
ajbspi-35950	96	14	.	.	PROPN
ajbspi-35950	96	15	р	р	PROPN
ajbspi-35950	96	16	.	.	PROPN
ajbspi-35950	96	17	,	,	PUNCT
ajbspi-35950	96	18	хайдаров	хайдаров	PROPN
ajbspi-35950	96	19	м	м	NUM
ajbspi-35950	96	20	.	.	PUNCT
ajbspi-35950	97	1	м	м	X
ajbspi-35950	97	2	.	.	PROPN
ajbspi-35950	97	3	фототоксические	фототоксические	PROPN
ajbspi-35950	97	4	и	и	PROPN
ajbspi-35950	97	5	фотоаллергические	фотоаллергические	PROPN
ajbspi-35950	97	6	реакции	реакции	PROPN
ajbspi-35950	97	7	при	при	PROPN
ajbspi-35950	97	8	использовании	использовании	PROPN
ajbspi-35950	97	9	современных	современных	PROPN
ajbspi-35950	97	10	лекарственных	лекарственных	NOUN
ajbspi-35950	97	11	средств	средств	NOUN
ajbspi-35950	97	12	и	и	PROPN
ajbspi-35950	97	13	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	X
ajbspi-35950	97	14	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-35950	97	15	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-35950	97	16	volume	volume	NOUN
ajbspi-35950	97	17	04	04	NUM
ajbspi-35950	98	1	issue	issue	NOUN
ajbspi-35950	98	2	06	06	NUM
ajbspi-35950	98	3	-	-	SYM
ajbspi-35950	98	4	2024	2024	NUM
ajbspi-35950	98	5	12	12	NUM
ajbspi-35950	98	6	american	american	ADJ
ajbspi-35950	98	7	journal	journal	PROPN
ajbspi-35950	98	8	of	of	ADP
ajbspi-35950	98	9	biomedical	biomedical	PROPN
ajbspi-35950	98	10	science	science	PROPN
ajbspi-35950	98	11	&	&	CCONJ
ajbspi-35950	98	12	pharmaceutical	pharmaceutical	PROPN
ajbspi-35950	98	13	innovation	innovation	NOUN
ajbspi-35950	98	14	(	(	PUNCT
ajbspi-35950	98	15	issn	issn	PROPN
ajbspi-35950	98	16	–	–	PUNCT
ajbspi-35950	98	17	2771	2771	NUM
ajbspi-35950	98	18	-	-	SYM
ajbspi-35950	98	19	2753	2753	NUM
ajbspi-35950	98	20	)	)	PUNCT
ajbspi-35950	98	21	volume	volume	NOUN
ajbspi-35950	98	22	04	04	NUM
ajbspi-35950	98	23	issue	issue	NOUN
ajbspi-35950	98	24	06	06	NUM
ajbspi-35950	98	25	pages	page	NOUN
ajbspi-35950	98	26	:	:	PUNCT
ajbspi-35950	98	27	8	8	NUM
ajbspi-35950	98	28	-	-	SYM
ajbspi-35950	98	29	12	12	NUM
ajbspi-35950	98	30	oclc	oclc	PROPN
ajbspi-35950	98	31	–	–	PUNCT
ajbspi-35950	98	32	1121105677	1121105677	NUM
ajbspi-35950	98	33	publisher	publisher	NOUN
ajbspi-35950	98	34	:	:	PUNCT
ajbspi-35950	98	35	oscar	oscar	NOUN
ajbspi-35950	98	36	publishing	publishing	NOUN
ajbspi-35950	98	37	services	service	NOUN
ajbspi-35950	98	38	servi	servi	PROPN
ajbspi-35950	98	39	некоторых	некоторых	PROPN
ajbspi-35950	98	40	растений	растений	PROPN
ajbspi-35950	98	41	//вопросы	//вопросы	PUNCT
ajbspi-35950	98	42	науки	науки	PROPN
ajbspi-35950	98	43	и	и	PROPN
ajbspi-35950	98	44	образования	образования	NOUN
ajbspi-35950	98	45	.	.	PUNCT
ajbspi-35950	98	46	–	–	PUNCT
ajbspi-35950	98	47	2020	2020	NUM
ajbspi-35950	98	48	.	.	PUNCT
ajbspi-35950	99	1	–	–	PUNCT
ajbspi-35950	99	2	№	№	NOUN
ajbspi-35950	99	3	.	.	PUNCT
ajbspi-35950	100	1	37	37	NUM
ajbspi-35950	100	2	(	(	PUNCT
ajbspi-35950	100	3	121	121	NUM
ajbspi-35950	100	4	)	)	PUNCT
ajbspi-35950	100	5	.	.	PUNCT
ajbspi-35950	101	1	–	–	PUNCT
ajbspi-35950	101	2	с	с	PROPN
ajbspi-35950	101	3	.	.	PROPN
ajbspi-35950	101	4	41	41	NUM
ajbspi-35950	101	5	-	-	SYM
ajbspi-35950	101	6	44	44	NUM
ajbspi-35950	101	7	.	.	PUNCT
ajbspi-35950	101	8	13	13	NUM
ajbspi-35950	101	9	.	.	X
ajbspi-35950	101	10	мурадова	мурадова	VERB
ajbspi-35950	101	11	р	р	ADP
ajbspi-35950	101	12	.	.	PROPN
ajbspi-35950	101	13	р	р	PROPN
ajbspi-35950	101	14	.	.	PROPN
ajbspi-35950	101	15	,	,	PUNCT
ajbspi-35950	101	16	хайдаров	хайдаров	PROPN
ajbspi-35950	101	17	м	м	NUM
ajbspi-35950	101	18	.	.	PUNCT
ajbspi-35950	102	1	м	м	X
ajbspi-35950	102	2	.	.	PROPN
ajbspi-35950	102	3	,	,	PUNCT
ajbspi-35950	102	4	омонов	омонов	VERB
ajbspi-35950	102	5	э	э	PROPN
ajbspi-35950	102	6	.	.	PUNCT
ajbspi-35950	103	1	м	м	X
ajbspi-35950	103	2	.	.	PUNCT
ajbspi-35950	104	1	оптимизация	оптимизация	ADJ
ajbspi-35950	104	2	терапии	терапии	PROPN
ajbspi-35950	104	3	больных	больных	PROPN
ajbspi-35950	104	4	с	с	PROPN
ajbspi-35950	104	5	открытоугольной	открытоугольной	PROPN
ajbspi-35950	104	6	глаукомой	глаукомой	PROPN
ajbspi-35950	104	7	с	с	PROPN
ajbspi-35950	104	8	учетом	учетом	NOUN
ajbspi-35950	104	9	параметров	параметров	PROPN
ajbspi-35950	104	10	состояния	состояния	ADV
ajbspi-35950	104	11	микроциркуляторного	микроциркуляторного	NOUN
ajbspi-35950	104	12	русла	русла	PROPN
ajbspi-35950	104	13	центральной	центральной	PROPN
ajbspi-35950	104	14	зоны	зоны	NOUN
ajbspi-35950	104	15	сетчатки	сетчатки	VERB
ajbspi-35950	104	16	//вопросы	//вопросы	PUNCT
ajbspi-35950	104	17	науки	науки	PROPN
ajbspi-35950	104	18	и	и	PROPN
ajbspi-35950	104	19	образования	образования	NOUN
ajbspi-35950	104	20	.	.	PUNCT
ajbspi-35950	105	1	–	–	PUNCT
ajbspi-35950	105	2	2021	2021	NUM
ajbspi-35950	105	3	.	.	PUNCT
ajbspi-35950	106	1	–	–	PUNCT
ajbspi-35950	106	2	№	№	NOUN
ajbspi-35950	106	3	.	.	PUNCT
ajbspi-35950	107	1	10	10	NUM
ajbspi-35950	107	2	(	(	PUNCT
ajbspi-35950	107	3	135	135	NUM
ajbspi-35950	107	4	)	)	PUNCT
ajbspi-35950	107	5	.	.	PUNCT
ajbspi-35950	108	1	–	–	PUNCT
ajbspi-35950	108	2	с	с	NOUN
ajbspi-35950	108	3	.	.	PUNCT
ajbspi-35950	108	4	6669	6669	NUM
ajbspi-35950	108	5	.	.	PUNCT
ajbspi-35950	109	1	14	14	NUM
ajbspi-35950	109	2	.	.	NUM
ajbspi-35950	109	3	олимжонова	олимжонова	VERB
ajbspi-35950	109	4	ф	ф	NOUN
ajbspi-35950	109	5	.	.	PUNCT
ajbspi-35950	110	1	и	и	PROPN
ajbspi-35950	110	2	др	др	PROPN
ajbspi-35950	110	3	.	.	PUNCT
ajbspi-35950	111	1	диета	диета	NUM
ajbspi-35950	111	2	и	и	PROPN
ajbspi-35950	111	3	образ	образ	ADJ
ajbspi-35950	111	4	жизни	жизни	NOUN
ajbspi-35950	111	5	до	до	INTJ
ajbspi-35950	111	6	и	и	PROPN
ajbspi-35950	111	7	во	во	NUM
ajbspi-35950	111	8	время	время	PROPN
ajbspi-35950	111	9	беременности	беременности	INTJ
ajbspi-35950	111	10	//журнал	//журнал	PUNCT
ajbspi-35950	111	11	академических	академических	PROPN
ajbspi-35950	111	12	исследований	исследований	PROPN
ajbspi-35950	111	13	нового	нового	PROPN
ajbspi-35950	111	14	узбекистана	узбекистана	PROPN
ajbspi-35950	111	15	.	.	PUNCT
ajbspi-35950	112	1	–	–	PUNCT
ajbspi-35950	112	2	2024	2024	NUM
ajbspi-35950	112	3	.	.	PUNCT
ajbspi-35950	113	1	–	–	PUNCT
ajbspi-35950	113	2	т	т	X
ajbspi-35950	113	3	.	.	NOUN
ajbspi-35950	113	4	1	1	NUM
ajbspi-35950	113	5	.	.	X
ajbspi-35950	113	6	–	–	PUNCT
ajbspi-35950	113	7	№	№	NOUN
ajbspi-35950	113	8	.	.	NOUN
ajbspi-35950	114	1	1	1	NUM
ajbspi-35950	114	2	.	.	X
ajbspi-35950	114	3	–	–	PUNCT
ajbspi-35950	114	4	с	с	NOUN
ajbspi-35950	114	5	.	.	PUNCT
ajbspi-35950	115	1	47	47	NUM
ajbspi-35950	115	2	-	-	SYM
ajbspi-35950	115	3	50	50	NUM
ajbspi-35950	115	4	.	.	PUNCT
ajbspi-35950	115	5	15	15	NUM
ajbspi-35950	115	6	.	.	PUNCT
ajbspi-35950	115	7	тилявова	тилявова	PROPN
ajbspi-35950	115	8	с	с	PROPN
ajbspi-35950	115	9	.	.	PROPN
ajbspi-35950	115	10	,	,	PUNCT
ajbspi-35950	115	11	худоярова	худоярова	NOUN
ajbspi-35950	115	12	д	д	X
ajbspi-35950	115	13	.	.	PROPN
ajbspi-35950	115	14	реалии	реалии	PROPN
ajbspi-35950	115	15	времени	времени	PROPN
ajbspi-35950	115	16	.	.	PUNCT
ajbspi-35950	116	1	синдром	синдром	PROPN
ajbspi-35950	116	2	гиперактивного	гиперактивного	VERB
ajbspi-35950	116	3	мочевого	мочевого	VERB
ajbspi-35950	116	4	пузыря	пузыря	PROPN
ajbspi-35950	116	5	и	и	PROPN
ajbspi-35950	116	6	пременопауза	пременопауза	VERB
ajbspi-35950	116	7	//журнал	//журнал	SYM
ajbspi-35950	116	8	биомедицины	биомедицины	NOUN
ajbspi-35950	116	9	и	и	X
ajbspi-35950	116	10	практики	практики	ADJ
ajbspi-35950	116	11	.	.	PUNCT
ajbspi-35950	117	1	–	–	PUNCT
ajbspi-35950	117	2	2021	2021	NUM
ajbspi-35950	117	3	.	.	PUNCT
ajbspi-35950	118	1	–	–	PUNCT
ajbspi-35950	118	2	т	т	X
ajbspi-35950	118	3	.	.	NOUN
ajbspi-35950	118	4	1	1	NUM
ajbspi-35950	118	5	.	.	X
ajbspi-35950	118	6	–	–	PUNCT
ajbspi-35950	118	7	№	№	NOUN
ajbspi-35950	118	8	.	.	PUNCT
ajbspi-35950	119	1	3/2	3/2	NUM
ajbspi-35950	119	2	.	.	PUNCT
ajbspi-35950	119	3	–	–	PUNCT
ajbspi-35950	120	1	с	с	PROPN
ajbspi-35950	120	2	.	.	PUNCT
ajbspi-35950	120	3	25	25	NUM
ajbspi-35950	120	4	-	-	SYM
ajbspi-35950	120	5	30	30	NUM
ajbspi-35950	120	6	.	.	PUNCT
ajbspi-35950	120	7	16	16	NUM
ajbspi-35950	120	8	.	.	PUNCT
ajbspi-35950	121	1	хайдаров	хайдаров	PROPN
ajbspi-35950	121	2	м	м	X
ajbspi-35950	121	3	.	.	PUNCT
ajbspi-35950	122	1	м	м	X
ajbspi-35950	122	2	.	.	PROPN
ajbspi-35950	122	3	,	,	PUNCT
ajbspi-35950	122	4	мурадова	мурадова	VERB
ajbspi-35950	122	5	р	р	ADP
ajbspi-35950	122	6	.	.	PROPN
ajbspi-35950	122	7	р	р	ADP
ajbspi-35950	122	8	.	.	PROPN
ajbspi-35950	122	9	,	,	PUNCT
ajbspi-35950	122	10	худойбердиева	худойбердиева	PROPN
ajbspi-35950	122	11	г	г	PROPN
ajbspi-35950	122	12	.	.	PUNCT
ajbspi-35950	123	1	с	с	PROPN
ajbspi-35950	123	2	.	.	PUNCT
ajbspi-35950	123	3	оптимизация	оптимизация	PROPN
ajbspi-35950	123	4	премедикации	премедикации	PROPN
ajbspi-35950	123	5	при	при	PROPN
ajbspi-35950	123	6	хирургических	хирургических	PROPN
ajbspi-35950	123	7	вмешательствах	вмешательствах	PROPN
ajbspi-35950	123	8	в	в	PROPN
ajbspi-35950	123	9	гинекологии	гинекологии	PROPN
ajbspi-35950	123	10	//достижения	//достижения	PUNCT
ajbspi-35950	123	11	науки	науки	PROPN
ajbspi-35950	123	12	и	и	PROPN
ajbspi-35950	123	13	образования	образования	NOUN
ajbspi-35950	123	14	.	.	PUNCT
ajbspi-35950	123	15	–	–	PUNCT
ajbspi-35950	123	16	2020	2020	NUM
ajbspi-35950	123	17	.	.	PUNCT
ajbspi-35950	124	1	–	–	PUNCT
ajbspi-35950	124	2	№	№	NOUN
ajbspi-35950	124	3	.	.	NOUN
ajbspi-35950	124	4	5	5	NUM
ajbspi-35950	124	5	(	(	PUNCT
ajbspi-35950	124	6	59	59	NUM
ajbspi-35950	124	7	)	)	PUNCT
ajbspi-35950	124	8	.	.	PUNCT
ajbspi-35950	125	1	–	–	PUNCT
ajbspi-35950	125	2	с	с	NOUN
ajbspi-35950	125	3	.	.	PROPN
ajbspi-35950	125	4	98	98	NUM
ajbspi-35950	125	5	-	-	SYM
ajbspi-35950	125	6	102	102	NUM
ajbspi-35950	125	7	.	.	PUNCT
ajbspi-35950	125	8	17	17	NUM
ajbspi-35950	125	9	.	.	PUNCT
ajbspi-35950	126	1	хайдаров	хайдаров	PROPN
ajbspi-35950	126	2	м	м	X
ajbspi-35950	126	3	.	.	PUNCT
ajbspi-35950	127	1	м	м	X
ajbspi-35950	127	2	.	.	PROPN
ajbspi-35950	127	3	,	,	PUNCT
ajbspi-35950	127	4	мурадова	мурадова	VERB
ajbspi-35950	127	5	р	р	ADP
ajbspi-35950	127	6	.	.	PROPN
ajbspi-35950	127	7	р	р	PROPN
ajbspi-35950	127	8	.	.	PROPN
ajbspi-35950	127	9	гепатотоксичность	гепатотоксичность	PROPN
ajbspi-35950	127	10	лекарственных	лекарственных	PROPN
ajbspi-35950	127	11	средств	средств	NOUN
ajbspi-35950	127	12	как	как	VERB
ajbspi-35950	127	13	одна	одна	PROPN
ajbspi-35950	127	14	из	из	PROPN
ajbspi-35950	127	15	проблем	проблем	PROPN
ajbspi-35950	127	16	современной	современной	PROPN
ajbspi-35950	128	1	медицины	медицины	PROPN
ajbspi-35950	128	2	//наука	//наука	PUNCT
ajbspi-35950	129	1	через	через	PROPN
ajbspi-35950	129	2	призму	призму	PROPN
ajbspi-35950	129	3	времени	времени	PROPN
ajbspi-35950	129	4	.	.	PUNCT
ajbspi-35950	129	5	–	–	PUNCT
ajbspi-35950	129	6	2020	2020	NUM
ajbspi-35950	129	7	.	.	PUNCT
ajbspi-35950	130	1	–	–	PUNCT
ajbspi-35950	130	2	№	№	NOUN
ajbspi-35950	130	3	.	.	PUNCT
ajbspi-35950	131	1	11	11	NUM
ajbspi-35950	131	2	.	.	X
ajbspi-35950	132	1	–	–	PUNCT
ajbspi-35950	132	2	с	с	PROPN
ajbspi-35950	132	3	.	.	PROPN
ajbspi-35950	132	4	46	46	NUM
ajbspi-35950	132	5	-	-	SYM
ajbspi-35950	132	6	49	49	NUM
ajbspi-35950	132	7	.	.	PUNCT
ajbspi-35950	133	1	18	18	NUM
ajbspi-35950	133	2	.	.	PUNCT
ajbspi-35950	133	3	эшназарова	эшназарова	PROPN
ajbspi-35950	133	4	г	г	PROPN
ajbspi-35950	133	5	.	.	PUNCT
ajbspi-35950	133	6	и	и	PROPN
ajbspi-35950	133	7	др	др	PROPN
ajbspi-35950	133	8	.	.	PROPN
ajbspi-35950	133	9	основные	основные	PROPN
ajbspi-35950	133	10	понятия	понятия	PROPN
ajbspi-35950	133	11	биотехнологического	биотехнологического	X
ajbspi-35950	133	12	получения	получения	PROPN
ajbspi-35950	133	13	лекарств	лекарств	NOUN
ajbspi-35950	133	14	//бюллетень	//бюллетень	PUNCT
ajbspi-35950	133	15	студентов	студентов	NOUN
ajbspi-35950	133	16	нового	нового	PROPN
ajbspi-35950	133	17	узбекистана	узбекистана	NOUN
ajbspi-35950	133	18	.	.	PUNCT
ajbspi-35950	134	1	–	–	PUNCT
ajbspi-35950	134	2	2024	2024	NUM
ajbspi-35950	134	3	.	.	PUNCT
ajbspi-35950	135	1	–	–	PUNCT
ajbspi-35950	135	2	т	т	X
ajbspi-35950	135	3	.	.	NOUN
ajbspi-35950	135	4	2	2	NUM
ajbspi-35950	135	5	.	.	X
ajbspi-35950	135	6	–	–	PUNCT
ajbspi-35950	135	7	№	№	NOUN
ajbspi-35950	135	8	.	.	NOUN
ajbspi-35950	136	1	2	2	NUM
ajbspi-35950	136	2	.	.	X
ajbspi-35950	136	3	–	–	PUNCT
ajbspi-35950	136	4	с	с	NOUN
ajbspi-35950	136	5	.	.	PROPN
ajbspi-35950	137	1	11	11	NUM
ajbspi-35950	137	2	-	-	SYM
ajbspi-35950	137	3	15	15	NUM
ajbspi-35950	137	4	.	.	PUNCT
ajbspi-35950	138	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-35950	138	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	NOUN
ajbspi-35950	138	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	NOUN